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ABSTRACT 
 
 
Beta Dose Calculation in Human Arteries for  
Various Brachytherapy Seed Types. (May 2003) 
Sung-Woo Lee, B.S., Hanyang University, Seoul, Korea; 
M. S., Hanyang University, Seoul, Korea; 
M. S., Texas A&M University, College Station, Texas 
Chair of Advisory Committee: Dr. W. Daniel Reece 
  
 This dissertation explores beta dose profile of microspheres packed in arteries, 
various source geometries of 142Pr that can be used for therapeutic purpose, and dose 
backscatter factors for selected beta sources.  
 A novel treatment method by injecting microspheres into feeding arteries of 
arteriovenous malformation (AVM) is under pre-clinical investigation. To optimize 
radiation dose to the clinically important area, i.e. arterial wall, preliminary dosimetric 
studies were needed. Monte Carlo calculations were performed for several geometries 
simulating arteries filled with microspheres packed by random packing methods. Arterial 
radii used in the simulation varied from 50 µm to 3 mm; microsphere radii varied from 
10 µm to 0.7 mm. Dose varied significantly as a function of microsphere size, for 
constant arterial sizes. For the same sizes of arteries, significant dose increase was 
observed because of inter-artery exposure for large arteries (> 0.1 cm rad.) filled with 
large microspheres (> 0.03 cm rad.). Dose increase between small arteries (< 0.03 cm 
rad.) was less significant. 
 iv
 The dose profiles of prototype 142Pr beta brachytherapy sources were calculated 
using MCNP 4C Monte Carlo code as well as dose point kernel (DPK) for selected cases.  
Dose profiles were similar to beta sources currently used indicating that 142Pr can 
substitute for current sources for certain cases and the DPK was closely matched with 
MCNP result. 
 Backscattering of electrons is a prominent secondary effect in beta dosimetry.  
The backscattering is closely correlated with factors such as geometry of source and 
scattering material, and composition of scattering material.  The backscattering factors 
were calculated for selected beta sources that are currently used as well as potentially 
useful sources for therapeutic purpose. The factors were calculated as a function of 
distance from the interface between water and scatterers. These factors were fit by a 
simple function for future incorporation into a DPK code. Backscattering effect was 
significant for short distance from the surface of interface between water and scattering 
material. 
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CHAPTER I 
 
INTRODUCTION 
 
Radiation therapy began in the early twentieth century and has now become the 
one of the major cancer treatments.  In order to reduce radiation dose to normal tissue, 
internal radiation therapy (brachytherapy) is sometimes preferred over external 
radiation beam therapy.  However, applications of beta-emitting radioisotopes for 
therapy purposes were not studied extensively until late 1980’s.  Recently, the use of 
beta sources in brachytherapy is expanding because it has several advantages over 
typical gamma sources for certain cases.   
First, beta sources offer advantages over higher-energy photon emitters in 
terms of ease of radiation shielding within the patient and radiation protection of 
medical personnel.  Second, the beta sources are preferred for treatment of some 
arterial diseases because the short electron range is suitable for thin arterial walls, and 
can spare healthy tissues around the target wall.  For example, there is hope that 
restenosis can be prevented while sparing surrounding tissues by the placing of a beta 
emitting brachytherapy wire or stent in the coronary artery concurrent with or after the 
angioplasty process (Fox 2002).  Ophthalmic diseases can also be treated by 
application of beta isotopes because of the short beta particle range.  Beta 
brachytherapy also can be applied to radiation synovectomy.  In this procedure, fluid  
 
This dissertation follows the format of Physics in Medicine and Biology.  
 2
 
removed from the joint is replaced by a radionuclide held in a liquid suspension that 
destroys the diseased tissue through irradiation (Johnson et al. 1993).  In another 
application, non-resectable hepatic tumors are being treated with beta particle emitting 
microspheres (Zavgorodni 1996, Campbell et al. 2000). Specifically, during this 
procedure very tiny spherical radioactive materials (microspheres: diameter ranges are 
in tens to hundreds of µm’s) are injected into a hepatic tumor artery through a catheter 
system to treat the disease site. This beta brachytherapy technique can significantly 
decrease the radiation doses to normal tissue without decreasing radiation dose to 
tumor cells.   
Arteriovenous malformation (AVM), especially cryptic AVM, can cause 
highly variable cerebral neurological defects.  Transient visual loss and ischemic 
attacks cause concern with regard to impending stroke or rupture of the AVM, 
indicating that after onset of symptoms, the AVM should be treated before it causes 
further damage.  However, it is sometimes too difficult or dangerous to treat the AVM 
with conventional surgical procedures because of size or location of the nidus.  
Fortunately, alternate methods exist to treat AVM radiosurgically after identifying 
nidus location by computerized tomography (CT) or magnetic resonance image (MRI) 
for dose planning.   
Brachytherapy provides an opportunity to reduce the dose to surrounding tissue 
during AVM treatment.  A novel AVM treatment method developed by Reece and 
Mawad (2001), is undergoing animal testing using injections of beta microspheres into 
the upper pole of the kidney to radiobiologically oblate small volumes within the 
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kidney.  Radiation dose levels for this technique are lower than the typical 
brachytherapy procedures for treating tumors.  Conventional cylindrical wire or stent-
type brachytherapy sources, currently used with angioplasty for treatment to prevent 
restenosis, may not be suitable for treating AVM because the artery shape (concavo-
convex) and diameter of blood vessels in the brain are somewhat different from 
cardiovascular arteries.  In the new technique, angiography is used to facilitate 
injection of a radioactive material in an artery just upstream of the malformation so it 
will close the pathway.   The radioactive spheres, carried in an embolic agent, would 
result in permanent closure of the blood vessels. This occurs because endothelial cell 
growth is enhanced by relatively low doses of beta radiation that damage arterial walls 
radiobiologically as well as mechanically, rather than suppressed as in intra-arterial 
brachytherapy.  Specifically, hyperplasia of endothelial cell of the vessel wall 
irradiated with beta emitters would close and block the blood stream.  The occluded 
nidus will not reopen and the AVM can be successfully treated.   
For this new treatment method, as outlined above, microspheres containing 
142Pr (microsphere diameter is approximately 50 µm) were used.  Animal pre-clinical 
testing, performed with pig’s kidney, is under way to test for clinical applicability.  
Little dosimetry, however, has been performed using Monte Carlo methods or dose 
point kernel methods.  
Some dosimetry has been done for other beta emitting microspheres but no 
careful study of packed microspheres has been done.  Existing microsphere dosimetry 
literature is qualitative at best.  A dosimetry study investigated 90Y-labeled 
microspheres for treating non-resectable hepatic tumors (Campbell et al. 2000, 2001).  
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They used a beta dose point kernel (DPK) method derived from Simpkin et al.’s point 
kernel data (1990) obtained by EGS4 Monte Carlo code, and calculated the dose as if 
from a point source, ignoring the mesh points lying within a microsphere.  In real 
situations, there could be significant perturbation effects from self-shielding, electron 
backscatter, etc.  Secondary radiation generation, including bremsstrahlung, can occur 
among the microspheres.  This is because there is significant heterogeneity of 
microspheres observed from resected organs of test animals’ kidneys (Mawad 2001) 
and human livers (Campbell et al. 2000).  From Campbell’s data, the injected 
microspheres tend to deposit in clusters rather than uniformly spaced single spheres.  
They report that the greatest distance between clusters was between 400 µm and 800 
µm.  Just from this data, there could be significant dose perturbation that was ignored 
in their studies.  For example, the fact that 142Pr itself is a high Z material and has high 
density, so cluster formation of microspheres may have significant perturbation effect, 
was not considered by Campbell et al. (2000, 2001) which used 90Y-labeld 
microspheres.  In this project, dose absorption in different sphere formations for a 
given tissue volume was studied, using a simple geometry that simulate the artery as a 
cylinder packed with microspheres.  From a clinical point of view, the most critical 
dose points in the arterial wall are just a few mm across because hyperplasia is the 
mechanism for closing the artery.   
142Pr has never before been used as a brachytherapy source, making dose 
characterization necessary not only for the AVM treatment but also for other potential 
applications.  Therefore, dose characterization as a function of various source 
geometries is one of the objectives of this dissertation.  Geometries considered include 
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point, cylindrical wire, cylindrical shell, disk, and spherical shapes.  These geometries 
cover almost all the current types of brachytherapy sources.  For cylindrical geometry, 
including a cylindrical shell geometry that mimics a stent, dose as a function of axial 
distance was compared with previous studies.  Dose rate as a function of a distance 
was compared with that reported in several studies for similar types of radioisotopes 
such as 32P (Prestwich et al. 1995) or 90Sr/90Y.  Dose rate as a function of the diameter 
of a spherical source is complicated by self-absorption within the source; this effect is 
also explored. 
In this study, both DPK and Monte Carlo methods were used to cross check 
results for 142Pr.  The Monte Carlo code, MCNP 4C (Briesmeister 2000), developed by 
Los Alamos National Laboratory, was used for complicated geometries, such as those 
involving a large number of microspheres.  The DPK method was used to calculate 
doses for relatively simple geometries, and the results were compared with the MCNP 
calculations.  For electron simulation, MCNP can simulate physical interactions such 
as collision stopping power, multiple scattering, energy straggling, bremsstrahlung 
production, and knock-on electrons, all of which are difficult to estimate for complex 
geometries using a DPK method.  For the DPK method, a code fashioned after 
VARSKIN MOD2 (Durham 1992) was used.  This code was initially developed for 
radiation protection purposes specifically for hot particle dosimetry in nuclear power 
plants.  The code uses Berger’s point kernel data (1971) for its calculations, and 
SADDE MOD2 (Reece et al. 1989) as incorporated in the VARSKIN package, was 
used for the dose calculation of beta emitting sources that have continuous beta energy 
spectra. 
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Backscatter factors, one of the most important secondary effects in beta 
dosimetry, were calculated as a function of depth from the interface between the water 
and selected source matrix materials, calcified plaques, and contrast agents.  
Previously, backscatter factors for beta particles have varied depending on the 
experimental setup and detector resolution for calculation, and were generally 
performed for monoenergetic electron beams, which make direct application of these 
factors to beta sources difficult.  The calculated values in this research can be readily 
incorporated into DPK methods using an analytical fit approach.  This model can also 
aid in choosing a source matrix or mixing materials for beta brachytherapy sources.  
Backscatter factor calculations were carried out using MCNP 4C for beta sources 
currently in use as brachytherapy seeds (32P and 90Sr/90Y), as well as other sources 
with potentially useful sources (45Ca, 142Pr and 185W).   
Briefly, this study is a careful study of a wide range of geometries, sizes, and 
receptor artery sizes in brachytherapy in brain arteries.  Effects of geometry, inter-
shielding, bremsstrahlung, and backscatter are presented here to help pave the way for 
further use of microspheres for therapeutic applications. 
 
 
 
 
 
 
 
 7
CHAPTER II 
 
THEORY 
 
II-1. Restenosis  
The formation of plaque, a process called atherosclerosis, gradually reduces 
artery lumen and results in a change in blood flow and oxygen delivery to cells.  
Collagen and elastin are produced and accumulate in intima, leading to focal 
thickening where platelets and cholesterol soon begin to adhere to the endothelium.  
As this process continues, lipids stacked up in the intima form yellow fatty streaks, 
leading to the formation of fibrous plaque.  Eventually, a complex lesion develops as 
the core of the fibrous atherosclerotic plaque necroses, calcifies, and hemorrhages.  
This induces a reduction in blood flow, platelet aggregation, and ultimately the 
formation of thrombosis with consequent myocardial ischemia and infarction.  
Restenosis after an angioplasty follows a similar course; angioplasty leads to a fracture 
of the atherosclerotic plaque, and over weeks to months the neointima becomes less 
cellular and healing site begins to resemble a fibrous plaque.  In about 40% of the 
angioplasty patients the neointimal hyperplasia is excessive and results in clinically 
symptomatic restenosis within three to six months (Nath et al. 1999a).  
 
II-2. Arteriovenous malformation (AVM) and its treatment 
AVM is a leading cause of intracranial bleeding and hemorrhagic stroke in 
humans, particularly young adults.  Most intracranial AVMs involve only pial vessels, 
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but some involve both pial and dural vessels.  The majority of AVMs are of congenital 
origin, but those that involve the meningeal arteries or vertebral arteries that drain into 
the dural sinuses may be acquired.  Those AVMs that are only a few millimeters in 
size cannot be identified by neuroimaging and are referred to as cryptic.  Conversely, 
AVMs may be so large that occupy an entire cerebral hemisphere.  Although AVMs 
are usually present from birth, they are often asymptomatic for years.  However, 70% 
of AVMs produce symptoms in the second and third decades of life, and most are 
reviewed supratentorial.  Recurring headaches that are always on the same side are a 
frequent symptom, and may mimic migraines.  Deformities of the blood vessels of the 
brain can have a very high tendency to rupture, causing severe neurological damage, 
coma, or death.  An angiography picture and a schematic illustration of an AVM are 
displayed in figures II-1 and II-2.  
Several methods of treating these vascular lesions have been developed, but 
there is no ideal treatment available.  Current treatment options include surgical 
resection, stereotactic radiosurgery using multiple external radiation beams focused on 
the target or a new method of embolization through injection of foreign material into 
the arterial tree in an attempt to close the abnormal blood vessels.  Sometimes, 
combinations of these methods are used to enhance the result.  None of these 
treatments are ideal, but there are promising results in the literature indicating that the 
combination of embolization of the AVM followed by stereotactic radiation therapy is 
effective in curing these malformations. 
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Figure II-1.  Angiographic picture of typical AVM 
 
Figure II-2. Illustration of an AVM nidus. The small double arrows indicate the 
feeding arteries which penetrate into the nidus; the open arrow indicates the 
terminal feeder. Arrowheads show the nidus opacification via pial anastomosis 
and the black arrow indicates the artery passing through. In strategic 
embolization of an AVM, the marginal part of the nidus is obliterated through 
such penetrating feeding arteries, the terminal feeder is obliterated at the 
entrance of the nidus and the majority of the nidus is kept opacified via the pial 
anastomosis; from Nagashima et al. 2000.  
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One major consideration in radiosurgery of AVMs is their size.  The size of the 
AVM is not the deciding factor in the decision to use a LINAC or stereotactic 
radiosugery, but usually patients whose AVMs less than 25 cm3 are candidates for 
treatment with a linear accelerator (Nagashima et al. 2000).  
Specific endovascular techniques vary according to the anatomy of the lesion.  
Recent improvements in microguidewire and microcatheter technology have made it 
possible to treat previously unreachable and untreatable AVMs.  Using a radioactive 
embolic material spares more healthy tissues in the brain compared to external beam 
therapy.  The embolization helps to obliterate the AVM, as well as providing radiation 
therapy to the vascular bed where the embolic agent is delivered (Mawad 2001, see 
figure II-3).  In this study, 142Pr was identified as an ideal radioactive embolic agent 
for treating AVM and possibly hypervascular tumors i.e., those types of cancer that 
have a rich blood supply feeding the tumor cells. 
 
II-3. Current beta brachytherapy sources and methods 
As stated in the previous chapter, the history of beta brachytherapy is very 
short compared with conventional gamma brachytherapy; practical application in 
human arterial trials began only in the mid 1990s.  Typically, beta sources are placed 
in the artery by percutaneous transluminal coronary angioplasty (PTCA).  A small 
catheter is passed into the coronary using radiographic guidance, which is then used to 
expand a small balloon to the desired diameter.  A beta source is then placed in the 
space thus treated.  There are several seed types used in this procedure, such as solid 
cylinder/wire such that the source is impregnated or sealed in the wire, liquids in the  
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(a) Microsphere emboli and cortical atrophy in a medium sized artery  
 
 
 
(b) Thrombosis associated with microsphere emboli in a medium sized artery 
Figure II-3. Embolization animal study (kidney of pig) by Mawad 
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angiography balloon, and stent type.  For ophthalmic disease, three types of 
ophthalmic applicators are being used (Soares et al. 2001):  A planar source with the 
radioisotope placed on the top of the planar structure, a disk type source, and a 
concave source. 
  Solid wire sources have limitations in that their size and stiffness sometimes 
prevents their entry into the artery (Fox 2002).  In addition, without the support of a 
centering device, uniform irradiation to the arterial wall cannot be guaranteed.  
Because of this, radioisotopic liquids are often used instead, as the source is then 
automatically centered in the arterial lumen.  However, liquid radioisotopes are not 
without their own problems; accidental rupture of the balloon must be avoided as these 
materials are bone-seeking radionuclides.  Usually, the inserted isotopes are 32P and 
90Sr and/or 90Y; however, 188Re has recently gained in popularity because of its short 
half-life and the fact that it can be obtained by generator milking from long-lived 
parent (188W: 69 days half-life).  This radioisotope is excellent for therapy as it is not 
bone seeking and is rapidly excreted from the patient in a breech-type accident.   
Initially, stents were devised to reduce the elastic recoil of the artery in 
angioplasty treatment.  However, its development initiated new treatment methods 
when it was realized that if the stents were made of radioactive material, further 
intervention in the artery for a separate irradiation procedure would not necessary.  A 
noted disadvantage of this technique, however, is that the dose to the arterial wall near 
the stent surface may be extremely large.  Additionally, because of the structural shape 
of the stent, dose oscillation occurs along the arterial surface.  This may have a 
significant negative impact on the treatment due to complete destruction of tissue.  
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This subsequently loosens the stent and can lead to thrombus.  This kind of effect 
contributes to restenosis despite the general fact that restenosis in the region of the 
stent is markedly inhibited if successful placement of stent is achieved (Nath et al. 
1999a).  In intravascular brachytherapy, beta-ray sources are typically used for their 
short range; however, the lesion area must be limited to between 0.1 and 0.3 cm 
thickness for treatment to be effective. A better characterization of dosimetry in this 
range will aid in the development of optimum clinical devices and methods.   
Because of the difficulties in precise experimental setup, many studies have 
used Monte Carlo or DPK calculations as a primary method.  These two methods have 
opposing advantages and disadvantages. Monte Carlo calculations are generally 
reliable for complicated source-to-target geometry and simulate particle tracks 
realistically, but are very time-consuming in computation. DPK calculations are much 
faster in computation, but the associated computer coding work can be complicated if 
the geometry is complex. Although the major disadvantage of the Monte Carlo 
calculations (i.e. time-consuming computations) has recently become less of an 
obstacle as fast computers are now easy to obtain without excessive financial sacrifice, 
in most clinical situations medical staffs still prefer DPK method because of the speed 
of calculation allows for exploring different treatment geometries, for example.  As 
Monte Carlo and DPK calculation methods are the main tools used to predict 
availability of beta ray sources, they were used to simulate the dose rates of point and 
sphere sources comparison with other beta-ray sources in this study. 
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II-4. Monte Carlo codes 
There are several Monte Carlo codes used in medical physics to establish dose 
protocol for external beams and isotropic brachytherapy sources.  The most widely 
used codes are EGS4 and MCNP.  Both codes have had their transport physics 
algorithms updated over the years by successive researchers.  The most recent version 
of the EGS4 code is EGSnrc (Karakow et al. 2000) that was released by NRCC 
(National Research Council of Canada).  The latest version of MCNP 4C, was released 
in 2000.  The electron physics in MCNP is similar to that of the ITS (Integrated Tiger 
Series). 
Electron transport in MCNP is based on the ETRAN series, originally 
developed at the National Bureau of Standards (now the National Institute of 
Standards and Technology) by Berger and Seltzer (1968).  ETRAN has been used in 
the calculation of therapeutic beam dosimetries, usually for electrons (Andreo 1991).  
The ETRAN model provides sophisticated electron transport simulation, but does not 
treat any geometry other than infinite media or plane parallel slabs of different 
materials.  In order to overcome this disadvantage, the ITS code consisting of TIGER, 
CYLTRAN and ACCEPT as developed by Halbleib (1988) was used.  These codes 
allow for transportation of electrons and photons down to 1 keV in plane-parallel slabs, 
cylindrical geometry or any combination of these geometries.   
 
II-4-1. Electron transport in MCNP 
Charged particle Monte Carlo codes, especially electron Monte Carlo codes, 
rely on a variety of analytic and semi-analytic multiple scattering theories.  Formulae 
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based on these theories use the fundamental cross sections and the statistical nature of 
the transport process to predict probability distributions for significant quantities, such 
as energy loss and angular deflection.  Major theories used in MCNP are Bethe-Bloch 
theory for mean energy loss, the Goudsmit-Saunderson theory for angular deflections, 
the Landau theory of energy fluctuations, and the Blunck-Leisegang enhancement of 
the Landau theory.  These theories rely on a variety of approximations that restrict 
their applicability, meaning that individually they cannot solve the entire transport 
problem (Hughes 1997).  
One of the main differences between EGS4 (EGSnrc) and MCNP is the 
methods by which they address secondary electrons (Jeraj et al. 1999); MCNP uses a 
Class I algorithm while EGS4 series uses a Class II algorithm.  Class I algorithms 
group all the interactions and use a predetermined set of path lengths.  Random 
sampling is performed at the end of the each step so that the energy is statistically 
conserved. On the other hand, in Class II algorithms the energy of the primary electron 
is affected by the secondary electrons.  However, the Class II algorithm used in MCNP 
4B for radiative loss has been modified to overcome the underestimation common to 
the Landau theory.  For more specifics about the physics used in the EGS4 series of 
Monte Carlo codes the reader is referred elsewhere (Nelson et al. 1985). 
 
II-4-2. Electron steps in MCNP 
In MCNP, the condensed random walk for an electron is considered in terms of 
a sequence of path lengths and monotonically decreasing energy.  The energy and path 
lengths are expressed as 
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where En-1 and En represent each energy grid, sn and sn-1 represent path lengths, and    
-dE/ds is the total stopping power in energy per unit length (Briesmeister 2000 and 
Hughs 1997).   
The energy loss per unit path length due to collisions that is less than a fraction, 
η, of the electron kinetic energy E is from the Berger’s formulation: 
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where, I is the mean excitation potential, NA is Avogadro’s constant, ρ is the density, 
MA is molar mass and Zav is the average atomic number of the material electrons that 
have negative charge and δ is the density effect correction factor, and specifically 
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and coefficient C is expressed as 
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where re is the classic electron radius.  In eq. (2-3), τ is electron kinetic energy and β 
equals the electron speed as a fraction of the speed of light c.  The relation between τ 
and β is: 
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where Zi are the atomic numbers, ωi are the weight fractions, and Ai are the atomic 
weights of the different elements in the material.  From eq. (2-1), ETRAN based codes 
customarily choose the sequence of path lengths sn such that, for constant k,  
1−= nn kEE .         (2-7) 
In this equation, k equals to 2-1/8, which accounts for 8.3% of energy loss per step.  The 
representation of electron trajectory as the result of many small steps will be more 
accurate if the angular deflections are small.  MCNP can divide the electron steps into 
smaller substeps.  A major step of path length s is divided into m substeps (s/m).  The 
m depends on average atomic number Z.  Appropriate values for m have been 
determined empirically, and range from m = 2 for Z < 6 to m = 15 for Z > 91.  MCNP 
allows m to be increased for a given material for use in specific cases, such as a very 
small region of detectors used to collect electron dose. 
  
II-4-3. Electron energy straggling 
Electron energy loss is stochastic process because the microscopic interactions 
by any specific particle take place randomly.  Therefore, even for a monoenergetic 
beam, a spread of energies occurs as the particles pass through a thick absorbing 
medium.  This phenomenon is called energy straggling and varies with the absorption 
depth along the particle path (Knoll 1999).  As distance increases, the distribution 
widens.  Then, near the end of the electron range, the distribution narrows again due to 
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the reduction of mean particle energy.  Therefore, energy loss cannot be expressed as 
simple average of∆.  It is the probability distribution f(s, ∆)d∆ that Landau expressed 
as 
λλφ ddsf )(),( =∆∆ ,       (2-8) 
where ∆ is energy loss, s is the step length and φ(λ) is a universal function of single 
scaled variable. 
 
II-4-4. Angular deflection by Gouldsmit-Saunderson theory 
 The ETRAN series of codes, including MCNP, uses the Gouldsmit-Saunderson 
theory for abnormally large angle deflections.  However, this distribution theory can 
be applied to much smaller path lengths and all scattering angles.  The angular 
deflection of the electron is sampled according to the distribution 
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where s is a substep in g/cm2, µ (= cosθ) is angular deflection at each substep, Pj(µ) is 
jth Legendre polynomial, and Gj is calculated from 
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where N is number of atoms.  The loss of electron energy along its track can be taken 
into account in the continuous slowing down approximation by substituting 
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where T0 is the initial electron energy, T1 is the energy reached after a path length s, 
and S(T)/ρ is mass stopping power in MeV.cm2/g. 
 
II-4-5. Bremsstrahlung in MCNP 
Sampling of bremsstrahlung photons is addressed at each electron substep.  
Tables determine the probability of bremsstrahlung production and new photon energy 
is sampled from the bremsstrahlung energy distribution tables.  Deflection of the 
photons can also be sampled from tabular data.  The direction of the electron is not 
affected by the generation of a photon, because it is controlled by multiple scattering 
theory. 
 
II-4-6. Knock-on electron treatment in MCNP 
Treatment of knock-on electron follows the MØller cross section, 
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where ε represents energy transfers as fractions of the electron kinetic energy E and τ 
is the electron kinetic energy in electron rest mass units.  Once energy has been 
sampled, the angle between the primary direction and the direction of the newly 
generated secondary particle is determined by consideration of the momentum.  The 
deflection is used for the subsequent transport of the secondary electron.  Sampling of 
the secondary particles does not alter either the energy or the direction of the primary 
electron. 
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II-4-7. Different electron energy indexing algorithm in MCNP 
The use of different electron energy indexing algorithms in MCNP 4C 
significantly affect the calculated dose (Shaart et al. 2002, Jeraj et al. 1999, Love et al. 
1998).  The default option uses MCNP-style or MCNP-inherent style algorithms; this 
feature can be enabled by using a DBCN card in the MCNP input.  This approach is 
called the bin-centered algorithm.  ITS-style algorithms can also be used, and follow 
the methods of ITS 3.0 (the latest version of ITS code), called the nearest boundary 
algorithm.  The MCNP-inherent algorithm uses cross section data from the energy 
group in which the electron begins, while ITS-style algorithms use the data closest to 
the boundary of the electron at the beginning of the step.  MCNP-(inherent) style 
algorithms result in higher dose collection than ITS-style, because MCNP-inherent 
style causes electrons to correspond to scattering power data at higher energies (Jeraj 
et al. 1999).  This result is verified later in this study during backscattering factor 
calculation.  According to Shaart et al. (2002), however, ITS 3.0 algorithms are 
recommended if one desires higher accuracy; the difference between these two 
indexing methods is displayed in figure II-4. 
 
  II-5. Dose Point Kernel (DPK) method 
In order to ascertain the validity of DPK method, the beta and gamma dose 
from 142Pr were calculated using modified VARSKIN (representative DPK code for 
beta dose calculation). The VARSKIN code is widely used in health physics to 
calculate skin dose from hot particles attached to the skin or clothes of workers in 
nuclear power plants.  Since this code considers the source to be located between the 
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Figure II-4. Energy group selection in MCNP 4C code 
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water-equivalent skin and air, modification of the code was needed before it could be 
used to calculate point and sphere sources in water.  The DPK code was originally 
based on VARSKIN MOD2 (Durham 1992) and modified for geometry input.  The 
VARSKIN code is based on Berger’s point kernel data (Berger 1971).  The kernel is 
mathematically expressed as 
90
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= ,              (2-13) 
where, 
 
r = a variable representing the distance between a source point and a dose point, 
k = a unit point conversion factor, 
Eβ = the average beta energy for the radioisotope, 
Y = the beta yield per disintegration, 
Fβ (r1/X90) = the scaled absorbed dose distribution as a function of the modified 
path length and the X90 (distance which 90 % of the beta energy deposited from 
a point source) distance, 
r1 = the modified path length between the source point and dose point, and 
ρ = the density of the irradiated medium. 
Beta energy used in the MCNP calculation was in the form of 100 discrete 
energies, obtained from Seltzer (2001), that were generated by LOGft program.  The 
DPK calculation used 150 discrete energies generated by SADDE MOD2.  The 
SADDE code (Reece at al. 1989) was developed to provide scaled absorbed dose 
distribution data for any beta-emitting isotope for use in VARSKIN.  Specifically, 
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average beta energy can be obtained from the following expression of beta spectrum 
integration, 
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This DPK method uses Newton-Cotes eight-panel quadrature routines to interpolate a 
point between dose point r1 and r1+1.   
In this study, dose delivered by the point source and sphere source was 
calculated using the DPK method.  For the sphere source, the dose integral is written 
as 
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where Sv is the volumetric source strength. The results of the modified code were 
compared to MCNP results as a function of source diameter.  In practice, a density-
scaling method was used for beta ray tracking in the source area.  For example, the 
sphere source used in this study was 3 g/cm3, and the radiation tracking distance can 
be obtained by 
i
i
idd ∑= ς ,         (2-16) 
where ςi and di represent scaling factors and path lengths for each medium, 
respectively. 
Gamma dose rates were calculated together using the specific gamma ray 
constant or exposure constant Γ, and defined as 
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which numerically expresses exposure rate per unit activity at unit distance, and is 
generally presented as R.m2/Ci.hr, where C represents the activity of a source and r 
represents the distance from that source.  The exposure rate was due solely to gamma 
rays, and excludes the affect of X-rays generated through internal conversion or 
bremsstrahlung X-rays.  If these secondary X-rays were included, the exposure rate 
would increase by up to 2%, which is not significant with regard to total dose rate.  
Consequently, the dose rate from gamma rays traveling in an attenuating medium with 
attenuation coefficient µ, at a distance r from source strength Sv is  
urv e
r
SrD −Γ= 2)(γ .        (2-18) 
If the gamma ray passes through several media with different densities, then the dose 
rate is calculated using the same equation as above, but the attenuation term is 
summed and expressed as 
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where ri is the distance traveled by gamma ray in medium i and µi is the attenuation 
coefficient of each medium i.  
 
II-6. 142Pr source 
142Pr emissions are about 99.98% beta rays (Emax = 2.16 MeV), 3.7% gamma 
rays (1.575 MeV), and very small portion X-rays and electron capture energies per 
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disintegration.  Since the half-life of this radioisotope is only about 19.12 hours, 
careful time management is essential for clinical application.  The gamma energy used 
in this calculation is listed in table II-1, and average gamma and X-ray energies were 
used.  Calculated energy including only significant contribution to total gamma dose, 
was 58.13 keV.  All data were obtained from http://t2.lanl.gov; only the gamma-ray 
portion under consideration is presented in the table for this calculation. The beta 
spectrum input was obtained from Seltzer (2001), NIST, and the data was normalized 
and incorporated into MCNP input.  The shape of the beta spectrum is shown in figure 
II-5. 
The calculation of beta spectrum is expressed briefly in eq. (2-14), and 
SADDE MOD 2 code was used for spectrum generation for DPK input as well as 
MCNP input.  The SADDE MOD2 used subroutine BETA, originally developed by 
Kansas University (Reece et al. 1989).   The algorithm used in the calculation is as 
follows.  
First, the value of Fermi function f(Z,W0), must be determined based on the 
maximum energy of beta particle, Emax, and the atomic number, Z, of the decay 
product.   This value of f(Z,W0) is then multiplied by the half-life of the daughter to 
obtain the value ft. The ft which depends only on Z, t and Emax, can be used to 
determine the degree of forbiddenness.  The ft values vary to 10 and 1018, therefore the 
log10(ft) is used to predict the degree of forbiddenness.  If an isotope has several decay 
modes, the half-life of the particular decay can be calculated by using the overall half-
life divided by the probability of the particular path.  The degree of forbiddenness is 
obtained by angular momentum, the parity change, and the log(ft) value.  
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Using these input data, BETA calculates a normalized beta spectrum, n(E), 
which is expressed as follows: 
1)
0
(max =∫ dEEE n .       (2-20) 
The calculated spectrum is divided into 150 energy bins and then interpolated into 
1500 values using a spline interpolation. The average energy of composite spectrum is 
calculated using the following: 
∫= E EdEECOMPEavg max0 )( ,          (2-21) 
where, COMP is an array storage.  With this calculation method, subroutine SADD 
calculates average energy and absorbed dose function, φβ(x).  The generated spectrum 
data is then incorporated into MCNP input and compared with the DPK calculation.  
The results are given in Chapter III. 
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Table II-1. Gamma energy for 142Pr used in this calculation  
 Gamma Yield MeV Gamma Yield × MeV 
2.21E-05 6.420E-01 0.000381528 
6.24E-05 3.472E-02    5.82591E-05 
3.41E-05 3.428E-02 3.14336E-05 
2.36E-05 3.930E-02 2.49404E-05 
1.76E-05 4.840E-03 2.29064E-06 
2.28E-04 5.088E-01 0.003119475 
3.68E-02 1.576 5.79968E-02 
0.0371878 (Total)  0.0581 (Total) 
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Figure II-5. Normalized beta spectrum probability of 142Pr 
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CHAPTER III 
 
MICROSPHERES IN BRAIN ARTERIES 
 
III-1. Microspheres in AVM feeding arteries 
 
Deposition patterns of the microspheres used in this study for AVM treatment 
in human brain are not well known because injection of microspheres has only been 
performed in animal tests using pig’s kidneys (see figure II-3) that are hopefully 
physiologically similar to arterial branch of human brain.  The deposition of the 
microspheres depends on the diameter of artery, blood flow rate, branching of arterial 
paths and their angles and any addition of embolic agent.  In addition, current CT 
resolution, typically as small as 1 mm (Yeung et al. 1996), is not great enough to 
describe the curvature between the microsphere and tissue.  However, this study 
explores a wide variety of sphere densities and artery sizes.  Consequently, prediction 
through the calculation of deposited microspheres in the artery maybe more practical 
than direct experimentation.  In this study, the brain artery was modeled as a simple 
cylinder rather than a bifurcated arterial branches, and the dose rate was observed in 
various source-to-detector geometries in the assumption that the cylinder is packed 
with microspheres in a variety of packing densities.   
 
III-2. Random close packing of spheres in a cylinder 
The dose rate to arterial walls by microspheres is strongly affected by the 
packing ratio of the microspheres.  Naturally, compact packing of microspheres in a 
 29
given volume would give the highest dose rate to the wall.  At present, Kepler’s theory 
that hexagonal close packing is known to be the densest packing method according to 
the published articles (Nolan et al. 1992, Torquato et al. 2000).  By this theory, 
packing ratio reached around 74% and this would be the highest packing ratio that can 
ever be achieved.  
However, it is impossible to achieve hexagonal close packing in this study.  
Particularly, hexagonal close packing would not happen in microsphere packing in 
arteries because packing of microspheres would take place randomly.  Therefore, the 
random packing model was used in this study, and this method has been used for 
various applications.  The applications include understanding the structure of living 
cells, liquids, granular media, glasses, and amorphous solids, etc. (Torquato et al. 
2000).  To predict actual packing, a Monte Carlo method which realistically simulates 
experiment has been used.  Results of this calculation rarely exceed a 64% packing 
ratio in any container (Nolan et al. 1992, Jodrey et al. 1985, Torquato et al. 2000).   
In this study, S3D® (Siams Ltd. website manual) was used to obtain input in 
the format to be used in MCNP calculations.  This program can assign the dimensions 
and shapes to be packed with spheres, including box, helix and cylinder options.  
S3D® users can choose a single diameter of spheres to pack or choose spheres with 
various size distributions.  Since the size of the microspheres used in this study can 
vary up to ± 7%, this factor was used to generate random packing (i.e., different sizes 
of spheres were simulated).   
The diameter of the cylinders mimicking an artery varied from 0.01 cm to 0.6 
cm, and the diameter of the microspheres varied from 10 µm to 0.14 cm.  The S3D® 
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also has graphic function to render the result of packing; as shown in figure III-1.  The 
simulation used in this algorithm is such that the spheres were generated by size 
distribution and dropped into the cylinder either from the center of the cylinder or 
from randomly chosen positions in side of the cylinder wall; in this study, the 
randomly chosen position option was selected.  The physical impact of the dropped 
sphere was not considered.  As the sphere touched other spheres, the bottom of the 
cylinder or the cylinder wall, it stuck to those obstacles and slid over the surface in the 
direction of the potential energy.  When the sphere arrived at a point of 3 intersections 
of surfaces (three spheres, 2 spheres and 1 plane, etc.) or a surface perpendicular to the 
direction of its fall, the falling movement of sphere was stopped.  The S3D®, packing 
algorithms are as follows.  
First, determine radius of the sphere and initial position of drop.  In this step, 
users can choose the position of drop around the desired dimension those can either 
center or each side of the corner of dimension.  Second, vertical fall is initiated until 
the sphere contacts something.  Third, the current set of restrictions is analyzed to find 
whether the position in the packing space is stable.  If not, choose the new direction of 
movement of the sphere center.  Relocation in any direction must satisfy the 
restrictions and form the minimal allowable angle (less than π/2) with the direction of 
the free fall of sphere.  If there is no direction to move and all angles less than π/2, 
stop and choose the next sphere for packing.  Fourth, determine the next movement 
direction of the sphere center.  It can either be a direct line or an arc segment.  Fifth, 
calculate current location of the sphere with respect to potential intersections with 
other spheres or the cylinder wall.  All points inside another sphere or beyond the wall  
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(a) 995 microspheres (dia.: 0.01 cm) packed in a 0.04 cm diameter artery 
(note: not to scale) 
 
 
 
 
(b) Cross sectional view of the packing 
 
Figure III-1. Random packing of microspheres in a cylinder (Graphics generated using 
S3D® computer program) 
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are rejected for the center of the packed sphere.  If finished, return to second step for 
further packing of microspheres. 
From the S3D® program, center points of the spheres were obtained and the 
packing ratio was calculated using EXCEL®.  The packing ratio was assessed by 
comparing the sum of the volume of microspheres to the cylinder volume; it was 
found to range between 48% and 52%.  In the real situation, the most densely packed 
microspheres presumably would not exceed this ratio as the density is lessened by 
blood flow and vessel movement.                    
 
III-3. Geometry used for multiple spheres 
The potential arrangements of microspheres within the arterial walls are 
various and very hard to characterize.  As mentioned in previous chapter, the simple 
geometry was used in this preliminary study, and this approach reasonable because the 
primary purpose of radioactive microsphere injection is embolization.  The highest 
dose that can be achieved with the smallest activity is by random close packing of 
microspheres in the artery.  Potential reduction of unnecessary radiation to the arterial 
wall by attaching microspheres to the arterial wall using acryl cyanate glue is still 
under investigation. 
In this study, radii of microspheres from 0.001 cm to 0.07 cm were simulated 
to account for natural variation, and the arterial radii chosen for the calculation were 
from 0.005 cm to 0.3 cm.  A 0.01 mm radius is the smallest size that the manufacturer 
can achieve within their quality control standard, and a microsphere with 53 µm 
diameter (26.5 µm radius) was actually injected into the kidney of pigs used in the 
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Reece and Mawad study (2001).  The 53 µm diameter microspheres closed the arteries 
well while saving healthy cells in the kidney (Mawad 2001). 
To study the effects of various arterial and microsphere sizes, concentric 
cylindrical ring-type detectors were placed.  The distance from the arterial wall was 
varied from 0.01 cm to 0.4 cm (see figure III-2. (a)).  This detector geometry was 
compared with plane-type geometry (see figure III-2. (b)).  This chapter focuses on 
brain arteries where the critical target is no more than 2.5 mm from the inner wall of 
the artery, while typical arterial diameter is 3 mm in coronary arteries.  As Fox (2001) 
mentioned, the longest distance of interest point from the source would be only about 
4 mm.  The height of the cylindrical ring varied between 0.2 mm and 0.04 mm 
depending on the height of arterial cylinder.  The thickness of cylindrical shell was 2 
µm up to 0.1 cm distance from the surface of the artery, and 20 µm thick beyond that 
distance.  The number of spheres packed in the cylinder was varied between 120 and 
995 spheres.  The maximum number of spheres was limited to 995 because the cell 
description of MCNP only allows less than 1000 words per cell. In the case of 
calculating the dose rate between the two cylinders or if there was a need to increase 
the height of cylinder, the cell transformation function embedded in the MCNP cell 
card was used to duplicate the sphere-packed cylinder.  Inter-shielding or dose 
enhancement effects between arteries filled with microspheres were also considered in 
this study.  The geometry used in the calculation was two identical arteries parallel 
each other with the detector located between them.  For this calculation, a thin plane 
detector was chosen such that wide side of the detector faced towards the artery.  The 
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(a) Concentric ring detectors 
concentric ring 
detectors 
 
 
 
 
 
 
 
 
 
 Series of plane detectors 
(b) Series of thin plane detectors that broad side towards the arterial wall 
Figure III-2. Source to detector geometry used for single artery 
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thickness of the detector was identical to that of cylindrical detector that was used for 
calculation of single artery.  The detector thickness was chosen to be 0.02 mm for all 
distances.  The width of each detector was 0.4 mm, and height of the detector varied 
from 0.4 mm up to 4 mm.  A schematic of the stacked detector volumes is shown in 
figure III-3.                                                        
 
III-4. Results 
III-4-1. Single artery filled with microspheres 
 Monte Carlo calculations were performed for combinations of microspheres 
and arteries with various radii.  The smallest microsphere diameter was chosen to be 
20 µm. The largest diameter considered in this study was 700 µm.  For arteries, 100 
µm to 6 mm diameters were chosen.  Diameter ratios (artery to microsphere) were 
usually between factor of around 2 (e.g. 3 mm diameter artery to 1.4 mm diameter 
microsphere) to 10 (6 mm diameter artery to 0.6 mm diameter microsphere).  Higher 
artery to microsphere ratios (i.e. smaller microspheres in a large blood vessel) were not 
considered because they would show almost the same dose characteristics as a solid 
cylindrical source.  In order to make the comparison among various source geometries 
comparable, the same detector size was used.  For this, a thin plane type detector was 
used rather than a concentric ring type detector.  However, in the case of a 0.6 mm 
artery and 53 µm microsphere (all diameters), the height of the cylinder was only 
about 0.55 mm because of the limitation of number of the MCNP cell description. 
Therefore, stacking up of several cylinders was needed to compare with other arterial  
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Figure III-3. Source to detector geometry used for perturbation effect between the two 
arteries 
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sizes.  Furthermore, usual detector volume of 0.4 mm wide × 0.8 mm high × 0.02 mm 
thick could not be used.  Instead, a 0.4 mm wide × 0.4 mm high × 0.02 mm thick 
detector was used. As shown in figure III-4, the smaller the microsphere and arterial 
size, the higher the dose rate observed at the closest detector location.  When the 
smallest artery and the smallest microsphere were considered, the dose rate was more 
than 1000 times higher than those of 3 mm and 6 mm artery sizes (all in diameters) 
filled with any size of microspheres for a given unit activity.   
The total dose to the arterial wall, Dtot, during the entire life of the microsphere, 
making the assumption that the microspheres were static and would stay in the same 
arrangement could be calculated as follows: 
dttDDtot ∫∞=
0
.
)( ,       (3-1) 
where 
teDD λ−= 0
.
,        (3-2) 
where D0 is the initial dose rate and λ and t are decay constant and elapsed time, 
respectively.  For AVM treatment, lesser dose is needed, therefore, a weaker source is 
used in order to induce hyperplasia of arterial wall rather than prevent it.  To achieve 
this goal, required cumulative doses are known to be less than 10 to 15 Gy.  To predict 
dose rate for any given situation such as clusters or embolic matrix, the maximum final 
target dose can be set to 15 Gy.  Then using the results obtained in this study, the 
initial source activity to achieve optimum treatment result can be calculated.  Using 
this approach, for example, a 100 µm diameter artery filled with 20 µm diameter  
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microsphere needs only about 3.3 Bq/microsphere to deliver 15 Gy at a depth of 0.1 
mm in the arterial wall. To obtain the same accumulated dose, in a case at the other 
extreme such as 3 mm diameter artery filled with 1.4 mm diameter microspheres, the 
activity must be increased to about 33000 Bq/microsphere or about 10000 times 
greater than the former case.  Furthermore, there could be significant dose variations 
observed for the latter case because large vacant areas can exist between the packed 
spheres.  While figure III-4 just illustrates the dose rate to the wall as a function of 
microsphere and arterial sizes, figure III-5 describes not only by variation of 
microsphere and arterial sizes, but also as a function of unit volume of microspheres.  
This figure is useful in terms of what volume of microspheres should be injected for 
delivering desired dose rate to arterial wall.  For example, a 2 mm (diameter) artery 
filled with 0.6 mm (diameter) microsphere (0.1cm_ar_0.03cm_sp) just delivers less 
than 60% of the dose of 100 µm diameter artery filled with 20 µm diameter 
microsphere (0.005cm_ar_0.001cm_sp) at 0.2 cm from artery wall. 
 
 III-4-2. Two arteries filled with microspheres 
In most practical cases, the feeding arteries to the AVM exist alongside other 
feeding arteries rather than in isolation.  It is unclear how nearby arteries affect each 
other in clinical situations.  Therefore, it is necessary to take into account enhancement 
effect of other nearby arteries filled with microspheres.  The sizes of the feeding 
arteries were assumed not to differ significantly from adjacent to the primary artery.  
This section, therefore, concentrates on the effect of the same size of arteries affected 
by a nearby artery filled with the same size of microspheres.  The geometry of the 
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detector to the source is previously depicted in figure III-3.  In order to observe the 
differences in dose delivery to the arterial wall and peripheral area, various arterial and 
microsphere sizes were simulated.  The smallest arterial size considered was 100 µm, 
packed with 20 µm (both are diameters) microspheres.  The largest artery considered 
was 3 mm, packed with 1.4 mm microspheres.  Distance (D, see figure III-3. (a)) 
between each cylinder (artery) varied between 1 mm and 5 mm.  The results indicated 
that dose enhancement is significant for the closest arterial wall (0.1 mm, d) to 0.5 mm 
distance, d, from the surface of the primary artery in the case of larger arteries filled 
with larger microspheres (see figure III-6 (a) to (d)).  In these cases, generally large 
arteries (2 mm to 3 mm diameter) with larger microspheres were more affected by the 
other artery for closer distance to it than the case of small arteries (0.1 mm to 0.6 mm 
diameter) with smaller microspheres.  For example, at the closest point to the 
secondary artery (see figure III-6 (a), d = 0.1 mm and D = 1 mm), dose enhancement 
by the other artery was more than 48 to 60% for larger artery group (2 mm to 3 mm 
diameter), but only just over 10% for the small arteries (0.1 mm to 0.6 mm) group. 
The difference between the two groups diminished as the distance, d, increases and 
(beyond the middle of the dose point between the two arteries, e.g. see figure III-6 (f) 
where D = 1 mm and d = 0.6 mm), no differences were observed for artery or 
microsphere size. 
Another significant effect is that where distance D is 3 mm, the discrepancy 
between the two groups was not observed. It may be that electron backscatter between 
the two arteries is prominent at this distance.  The electron backscattering factor will 
be discussed later in Chapter IV.  
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(a) Dose rate at 0.01 cm distance, d, from the primary arterial wall 
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(b) Dose rate at 0.02 cm distance, d, from the primary arterial wall 
 
Figure III-6. Dose rate ratio of two arteries filled with microspheres to one artery filled 
with microspheres as a function of distance from the primary artery (Note: Size and 
packing formation of two arteries are the same
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         (c) Dose rate at 0.03 cm distance, d, from the primary arterial wall 
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(d) Dose rate at 0.04 cm distance, d, from the primary arterial wall 
Figure III-6. Continued 
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(e) Dose rate at 0.05 cm distance, d, from the primary arterial wall 
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(f) Dose rate at 0.06 cm distance, d, from the primary arterial wall  
Figure III-6. Continued 
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III-4-3. Dose rate ratio of microsphere-filled artery to solid source-filled artery 
 Dose rate is affected greatly by the volume of the source, because 142Pr itself is 
a high Z material (the density of the microsphere is about 3 g/cm3), and the short beta 
particle range in the source material.  If the arterial size is relatively large, and the 
sphere size is also large compared to the beta range, vacant space in the arterial 
volume would be relatively larger than that in a small artery with smaller microspheres.  
All these factors affect dosimetry to arterial wall and make it difficult to predict. 
However, it is obvious that vacant space in the larger artery can potentially lower the 
dose rate because of less occupancy of source volume, while the relatively less 
absence of vacant space in small arteries filled with smaller microspheres producing 
higher dose rates.  This effect can be observed by comparison between the artery filled 
with microspheres and an artery filled with uniformly distributed source material.  As 
expected, dose rate was increased for smaller microsphere packed small arteries and 
decreased for the other case when these were compared with solid source filled arteries. 
 As shown in figure III-7, for the smallest artery (100 µm diameter) filled with 
smallest microsphere (20 µm diameter, 0.005cm_ar_0.001cm_sp), there was no 
significant difference between microsphere-packed cylinder and solid uniform source-
packed source. Discrepancies between the solid source artery and microsphere-filled 
artery were less than 11% up to 4 mm distant from the surface, and most of the 
discrepancies were less than 5%.  However, for medium size arteries (0.2 mm and 0.6 
mm), dose enhancement was 13-25% for points near the surface.  This may due to the 
fact that the escape of beta particles without interacting with high Z source media is  
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Figure III-7. Dose rate ratio between arteries filled with microsphere vs. artery filled 
with uniform source   
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more probable for small arteries.   Further away from the artery (around 0.8 mm to 1 
mm from the surface), the dose rate for solid artery was almost the same or slightly 
higher than that of microsphere-filled artery.  This small increase may be due to 
bremsstrahlung.  Since there is no vacant area (filled with water) in the solid cylinder, 
bremsstrahlung X-rays would be generated more than in microsphere-filled arteries.  
For larger arteries (1 mm to 3 mm) filled with larger microspheres, dose rate was 
decreased compared with solid arteries, as expected. 
 
III-4-4. Effects of cylinder height 
All the cylinders calculated in this chapter were around 10 mm height for 
comparison purpose.  For arteries filled with small microspheres, the height of the 
cylinder is smaller than in other cases, because of constraints in MCNP input 
discussed earlier.  Therefore, 100 µm artery filled with 20 µm diameter microspheres, 
whose original height is only 0.11 mm and for a 0.6 mm artery filled with 53 µm 
microspheres, the original height of cylinder was only 0.0523 mm.   
Calculations were performed for three times taller cylinders than the original 
cylinder, and the results were compared.  In order to compare differences between 
original and taller cylinder, the paste capability in MCNP was used.  Three identical 
cylinders were stacked and detector located in the middle of cylinder axis from the 
cylinder surface.  For the first case (50 µm radius artery filled with 10 µm radius 
microsphere), discrepancy between small and 3 times taller arteries was within 15% up 
to 0.03 cm from the surface.  However, discrepancies were increased up to 60% up to 
0.4 cm distance. Certainly, higher the height, the greater dose rate was observed. 
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For 0.03 cm radius artery filled with 53 µm diameter microspheres, the dose 
rate differed by 44% at only 0.1 mm distance from the arterial surface.  This 
discrepancy increased to more than 65% at 0.2 cm distant and beyond.  However, in 
order to compare other arteries, the height of these arteries increased up to around 10 
mm.  In these cases, it was found that differences of dose rate were saturated beyond 
around 8 mm height.  This height is close to electron range of 142Pr (around 0.88 cm).  
Therefore, the dose rate comparison would not deviate severely from this study even 
though the calculation was performed for shorter cylinders just less than 1 cm.  As 
shown in the angiographic picture (see figure II-1), the AVM arteries are severely 
warped in some regions, thus questions about specific effect of variation in height still 
remain for future study.   
 
III-4-5. Effect of detector geometry: concentric ring vs. plane type 
As shown in figure III-2, two types of detectors were used to assess doses from 
arteries.  The comparison between the cylindrical ring and plane type detector is 
shown in figure III-8; discrepancies between the two detectors were less than 10% at 
distances up to 0.2 cm from the surface, but greatly increased thereafter.  For a 0.15 
cm artery with 0.03 cm microspheres the difference was more significant than in 
smaller arteries, and this is due to discrepancies in detector volume.  As detector 
moves away from the cylinder, the volume of the concentric ring is gets larger, and 
this effect is more prominent for larger cylinders than small ones.  However, beyond 2 
mm from arterial wall, dose rate is significantly affected by detector geometry.  
However, as mentioned, these distances may not be important clinically to induce  
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Figure III-8. Dose rate ratio between plane cubic detectors vs. concentric ring 
detectors 
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hyperplasia of arterial wall.  Therefore large discrepancies beyond 2 mm from artery 
by using different detector would be meaningless for clinical application.  
 
III-4-6. Dose contribution by gamma energy emission from source 
As stated in previous Chapter II, 142Pr emits not only beta particles but also 
gamma rays.  However, the gamma energy contribution to dose as a fraction of total 
dose was less than 1/1000.  Most of the dose was from beta particles for small arteries 
with small microspheres for clinically significant distance away from the arterial wall 
(up to 4 mm).  The gamma contribution was less for larger arteries with large 
microspheres.  In order to obtain reasonable gamma energy contribution data by 
MCNP calculation, more than 0.1 billion or even order of billions of particle histories 
would be needed.  Therefore, it would not introduce significant error even if the 
gamma contribution of 142Pr is ignored. 
 
III-5. Conclusions and discussions 
Dose rates around cylinders randomly packed with microspheres was 
calculated using MCNP.  The AVM feeding arteries were simplified as a cylinder 
packed with microspheres.  With this geometry, various dose rate effects as a function 
of microsphere and arterial size were observed.  The dose rate was affected by packing 
formation, diameter sizes of artery and microsphere, distance between neighboring 
artery, and length of artery. 
Small arteries filled with relatively small microspheres have higher dose rates 
around arterial wall than arteries filled with relatively large microspheres.  If the ratio 
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of diameter of artery to microsphere diameter is about a factor of 10 (e.g., 0.3 cm 
artery with 0.03 cm microsphere), dose rate is significantly higher than the same sizes 
of arteries are filled with larger sizes of microspheres.   
Specifically, packing formation greatly affected the large artery (0.1 to 0.3 cm 
radii) with large microsphere size probably because of the vacant spaces between 
microspheres.  In addition, there were large variations in dose distribution along the 
arterial wall for large arteries with large microspheres.  To overcome dose rate 
variation by this effect, several calculations were done and averaged, particularly for 
large arteries with large microspheres, for reasonable comparison with other arteries.  
On the contrary, small arteries with small microspheres (50 µm radius artery filled 
with 10 µm radius microspheres) was affected less by packing formation.  For this 
case, it is practical to assume the cylinder as simple cylindrical or line source.  This 
effect is closely related to beta particle range and the combinations between sphere and 
arterial sizes because microsphere itself is a high Z material.   
Dose rate ratios between the same sized cylinder filled with microspheres and 
solid cylindrical source occupying the whole cylinder were compared.  The result was 
interesting because of strong dependence on the arterial size.  As arterial size increased, 
the dose rate of solid source was higher than that of cylinder filled with microspheres. 
Height of simulated cylinder was varied but was usually longer than 1 cm 
except in certain cases where small arteries were filled with very small microspheres 
and when medium size arteries were filled with small size microspheres.  If the height 
is about 1 cm, which is longer than the electron particle range of 142Pr, a few 
discrepancies exist.  However, by using duplication function embedded in MCNP, the 
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same size of cylinders were stacked and calculated again.  For longer cylinder height, 
the first case (100 µm diameter artery filled with 20 µm diameter microsphere, height 
is 0.11 mm) was not affected significantly, but a second case (0.6 mm diameter artery 
filled with 53 µm microsphere, height is 0.0523 mm) was affected because of the very 
short length of the cylinder.  This study was performed for short artery sections, and a 
more specific study of dose as a function of cylinder height remains for the future.   
Significant differences were observed as a function of a shape of detector.  For 
cylindrical ring detectors, showed lower dose rates than that of plane cubic detector.  
However, the effect was significant only beyond 2 mm from the surface where clinical 
implication is less important.  In addition, the plane detectors used in this study were 
used for comparison purposes only, so discrepancies from this effect could be minimal.  
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CHAPTER IV 
 
DOSE CALCULATION OF 142Pr IN WATER FOR VARIOUS  
BRACHYTHERAPY SEED TYPES 
 
IV-1. Introduction 
There are widely used sources such as 32P, 90Sr/90Y with established dosimetry; 
however, exploring other beta emitting isotopes is still attractive because some useful 
beta emitters may exist that can overcome several problems associated with current 
sources available for brachytherapy use.  These problems include lower beta energy, 
high costs, and chemical toxicity to human body, among others. In this chapter, 142Pr, a 
beta-emitting radioisotope, which has potential applications in intra-arterial and 
ophthalmic diseases was studied for various source geometries.  
Point, solid cylinder, cylindrical stent, disk, and sphere geometries cover the 
range of current applications. In traditional interstitial brachytherapy, which typically 
utilizes a gamma source with a dose rate specified at 1 cm from the source as a 
reference position for longer distance, the effects of low-energy photons such as 
secondary X-rays and electrons were sometimes being ignored, but beta and gamma 
doses around single microsphere were investigated using MCNP as well as DPK.  
Results of MCNP and DPK were compared and differences between these two 
methods were found, particularly near the end of the range of the beta particles.   
In this chapter, two beta spectrum generation methods, SADDE and LOGft, 
were used and differences in dose profiles depending on the input spectrum were 
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observed too.  
 
IV-2. Source and detector geometries 
The geometries considered in this study are point, solid cylinder (wire), stent 
(cylindrical shell), disk, and sphere. These geometries bound all the major seed types 
that are commonly used for therapeutic purposes.   
The point source was a dimensionless point located at the center of a sphere of 
water.  In the Monte Carlo calculations, the detectors were spherical concentric water 
shells 0.002 cm thick, with their midpoints located between 0.01 cm and 1 cm. 
For the wire source, an area 2 cm in length and 0.3 cm in diameter was 
simulated in a large water phantom (diameter=30 cm) for comparison with the stent 
type source. The wire was assumed to be composed solely of praseodymium (Z=59).  
The radiation from the source was deposited in concentric rings 1 cm height and 0.002 
cm thick in the axial direction of the source. 
The stent type source could be compared with published results (Prestwich 
1996), and has source geometry identical to the wire except that the source region is a 
2.5 × 10-5 cm thick cylindrical shell.  The detectors were located in a similar manner as 
with the wire source.  The cylinder material was composed of water, because the 
source material is very thin and the composition of the interior of the cylindrical shell 
depended on the properties of the angioplasty material.   
The simulated ophthalmic applicator was a disk source 1 cm in diameter.  The 
disk was located on the center of a plane in a large spherical phantom (diameter = 30 
cm), and the thickness was essentially zero. The detectors were small cylinders 
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oriented with the circular face toward the disk, and these were aligned along the 
central axis of the disk.  The height and diameter of the cylinder were 0.006 cm and 
0.6 cm, respectively.  
Spherical sources were considered in this study because this form is useful for 
hepatic tumor and arteriovenous malformation (AVM) treatment.  In order to mimic to 
a realistic application, the physical parameters of the microspheres used in the animal 
tests were used as a benchmarking source.  Dose rate calculation was performed as a 
function of sphere diameter.  Contents of microspheres are: 10.5a/o praseodymium, 
62.3a/o oxygen, 10.5a/o aluminum, and 15.8a/o silicon, and the density of this material 
is approximately 3 g/cm3.  The radii of the microspheres varied from 25 µm to 0.15 cm, 
and the dose profiles for selected diameters were calculated. The calculation was 
performed using MCNP as well as a DPK method.  Source to detector geometry was 
essentially that of a point source, and the source sphere was located at the center of a 
concentric spherical water shell (detector).   
 
IV-3. Monte Carlo calculation 
This study used MCNP (Briesmeister 2000) to perform the Monte Carlo 
calculation.  Although the code has the ability to transport neutron, electron and 
gamma particles independently or in a couple or a triplet, this must be initiated by one 
of the particles.  Because 142Pr emits electron and gamma particles simultaneously, 
separate calculations were needed and the sum of them taken as the total dose rate.  
For electron transport, all secondary particle effects (including bremsstrahlung) were 
simulated together by coupled electron-photon transport.  *F8 tally was used to 
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express absorbed dose in energy (MeV), and it was divided by the mass, and then 
multiplied by appropriate conversion factor to get dose. The ITS 3.0-style energy 
indexing algorithm was selected over the inherent MCNP-style algorithm through an 
option in the DBCN card, because the ITS 3.0-style algorithm gives results closer to 
those achieved through experimentation.   
In order to reduce result error to within 10%, differing numbers of histories 
were chosen depending on the detector size and according to the source geometry.  
Generally, 10 million particles were initiated for electron transport and 100 million 
particles were chosen for gamma transport. 
 
IV-4. Comparison of MCNP fit results with DPK results 
The MCNP results were fitted with the function presented by Prestwich et al. 
(1995).  The function was fitted for dose around a 32P stent, but its application to 
sphere source was reasonably accurate up to 0.5 cm from the sphere surface.  The dose 
distribution is expressed as 
)()()( 2211 xFaxFaxD += ,       (4-1) 
where D represents dose rates in mGy/MBq-h.  Specifically,  
3/1
1 /)( xexF
xλ−
= ,        (4-2) 
where x is the distance from the sphere surface. This term accounts for smaller 
distances from the surface where dose is higher, and the second term is for larger 
distances where relative dose rate is lower.  The second term is expressed as 
).1/()( /)(2 0
αµ xxx eexF −− +=        (4-3) 
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According to Prestwich et al. (1995), the six parameters (a1,λ, a2,µ and α) are 
inversely proportional to volume of a source, but this effect was only observed for 
larger diameters of microspheres (0.1 cm to 0.3 cm) in this study. 
 
IV-5. Results and discussions 
IV-5-1. Dose rate for the point source  
Dose rates for the point 142Pr source were calculated using DPK as well as 
MCNP Monte Carlo method. Beta emission spectra data were incorporated into 
MCNP input; spectral data generated by both LOGft and SADDE MOD2 were 
compared.  As shown in figure IV-1, discrepancies were observed at the end of the 
electron path.  LOGft-generated beta input showed higher dose rates than the SADDE-
generated input for all distances except for distances very close to the detector point (~ 
0.04 cm).  DPK calculation based on the SADDE-generated beta spectrum showed 
results similar to the MCNP calculation. However, it showed larger discrepancies at 
the end of the beta particle range (~ 0.88 cm range: 1.8 × X90).  Compared to MCNP 
calculations, DPK method underestimated the dose rate except at short distances (~ 
0.04 cm).  This effect may be caused by energy straggling due to secondary particle 
effect that is not satisfactorily incorporated into point kernel data.  It is encouraging 
that results obtained using the same spectrum data (SADDE MOD2) for both MCNP 
and DPK calculations matched well, with less than 20% difference in dose rate for up 
to 0.6 cm distance.  However, these results indicate that using different spectrum 
generation codes may introduce large differences in dose rate at greater distances. 
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Figure IV-1. Dose rate of 142Pr point source as a function of different spectrum 
generation code and calculation method (Note: MCNP-ITS and MCNP-Style represent 
LOGft generated beta spectrum and use of ITS 3.0 and MCNP style algorithm, 
respectively.  MCNP-SADDE used SADDE MOD2 generated beta spectrum and used 
ITS 3.0 algorithm. ITS 3.0 algorithm was used hereafter mentioned otherwise) 
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IV-5-2. Dose rate for stent and solid wire sources 
To investigate the applicability of 142Pr for use in a stent, dose rates were 
calculated as a factor of axial distance from the surface of the source.  Dose rate 
decreased rapidly as the distance increased, and contribution by the 3.7% gamma 
energy portion dominated at 0.81 cm and beyond from the source surface (figure IV-2).  
Because of gamma energy contribution, the dose rate did not significantly decrease in 
the extremity of the range.  Figure IV-3 shows that in the wire geometry, the dose rate 
fall-off was much quicker than in that of the stent. Comparison of dose decrease with 
32P stent is shown in figure IV-4.  At a distance of 0.65 cm from the source surface, 
dose rates were 0.15% (wire) and 0.137% (stent) of those at 0.01 cm from the surface.  
However, the effect of self-absorption of the beta ray in solid medium was significant 
in the vicinity of the source surface area; therefore dose rate for the wire was much 
lower than for the stent.  At a distance of 0.01 cm from the source surface, the dose 
rate from the stent was more than 5.8 times higher than that of the solid wire source. 
Although a stent may induce restenosis in some cases (Nath et al. 1999), the 
stent type is better suited to irradiation of unwanted healthy tissues than the solid wire 
type because of higher dose rate in short distance and rapid dose fall-off at longer 
distances.  Therefore, design improvement of the stent source and clinical application 
technique would yield higher dose rate to the arterial wall with smaller activity. 
Prestwich (1995), using the same 32P geometry, calculated a dose rate 0.05 cm from 
the source surface of about 540 mGy/MBq-hr.  In this study, the dose rate of 142Pr was 
estimated to be around 440 mGy/MBq-hr at the same distance. 
This is 0.83 times smaller than that of 32P calculated, but dose rate decrease as  
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Figure IV-2. Dose rate of 142Pr stent as a function of distance 
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Figure IV-3. Dose rate of 142Pr wire (solid cylinder) as a function of distance 
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a function of distance was not significant because mid-range electron energy (~ 
1MeV) of 142Pr spectrum contributes to dose profile at greater distances.  Although 
gamma contribution from 142Pr in the 0.4 to 0.7 cm range was not a primary factor of 
the total dose rate, a significant amount of gamma energy was observed in the tail of 
the straggling range.  However these dose rates are not significant when considering 
the distances in question in a clinical situation.   
Direct comparison of these two radioisotopes can be misleading because 
detector size and assembly conditions differed slightly.  Another possible reason for 
the slightly smaller value of 142Pr when calculated by MCNP is that a DPK calculation 
usually overestimates dose at very short distances from the source.  This effect may 
not have had much impact on the DPK method in this study, but if Prestwich used a 
similar algorithm, it may have contributed to the overestimation.  Even from these 
calculations, however, 142Pr guaranteed a dose rates per activity equal to that of 32P in 
the points within the target area of clinical interest.  Furthermore, because 
praseodymium is not known to be a bone-seeker such as phosphorus or strontium, 
shielding elements, which can affect dose characteristics, may not be necessary as for 
32P or 90Sr/90Y.   Also praseodymium can easily be mixed with other inorganic 
materials in high concentration to form chemically stable glass-like material, and this 
is another physical advantage of using 142Pr source rather than using 32P and 90Sr/90Y 
for brachytherapy purpose.  
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IV-5-3. Dose rate for a disk source 
Characteristics of 142Pr as an ophthalmic applicator were simulated by a simple 
disk source (figure IV-5).  The result was compared with Cross et al.’s (2001) results.  
In their results, 106Ru/106Rh and 90Sr/90Y are comparable to 142Pr because of their 
geometrical similarities.  Concave ophthalmic applicators were excluded from the 
comparison because the differences in geometry lead to a meaningless comparison; 
Cross et al. (2001) found up to 30% difference between the experimental and 
theoretical calculation results for the same concave type applicator. 
Although the diameters of the ophthalmic applicator used in this study and that 
of Cross et al. (2001) differed, similar beta particle ranges made the difference 
between 142Pr and 90Sr/90Y negligible.  For this comparison, the 90Sr/90Y disk 
applicator was NEN 0258 made by New England Nuclear.  The activity is dispersed 
through material 1 mm thick and 0.86 mm in diameter.  It is mounted on a thick 
stainless-steal backing and covered by a 0.1 mm stainless window.  As shown in figure 
IV-6, dose rate was normalized (dose rate at distance 0.1 cm from the source 
normalized to 1) and the data obtained from Cross et al. (2001) were plotted together 
with results of this study for comparison purposes.  Relative dose decrease for 
106Ru/106Rh, however, was not as significant as other two isotopes due to its higher 
beta energy (Emax = 3.54 MeV).  Active diameter of this source is 20.5 mm and is 
mounted on a silver backing, about 0.9 mm thick, and covered by a 0.1 mm thick 
silver window (manufacturer: BEBIG Trade Inc.).  
Due to similar maximum beta energies, the 90Sr/90Y (Emax = 2.28 MeV) disk 
source showed dose fall off patterns similar to that of 142Pr (Emax = 2.16 MeV).  
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Figure IV-5. Dose rate of 142Pr disk source 
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Figure IV-6. Relative dose rates of 142Pr, 106Ru/106Rh and 90Sr/90Y disk sources (Cross 
et al. 2001).  Dose rate normalized to 0.1 cm distance from the source surface.  (Note: 
Diameters are 2.05 cm and 0.86 cm for 106Ru/106Rh and 90Sr/90Y, respectively) 
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For example, relative dose rates for 142Pr and 90Sr/90Y were 1.4 and 1.34 at 0.05 cm, 
respectively, when the reference point (the point where relative value equals one) was 
0.1 cm.   
As described in section IV-2, the geometry of 142Pr was simplified to a 
dimensionless thickness while the 90Sr/90Y sources used in the Cross (2001) were 
encapsulated in thin silver.  In a real-world application in which a source-backing 
material is present, the relative dose rate of 142Pr could be different from this result 
because of the shielding effect and backscatter.  However, the results indicate that the 
efficacy of 142Pr as an ophthalmic applicator is promising compared to sources 
currently being used. 
 
IV-5-4. Dose rate for sphere sources as a function of radius 
Spherical geometries of radioactive material have been investigated for 
radiation protection concerns for exposures from a hot particle.  Another potential area 
of interest in spherical source geometry is radioimmunotherapy applications.  For 
radioimmunotherapy, dose has been calculated in a uniformly distributed source 
sphere as absorbed fractions (Siegel et al. 1994).  However, in most hot particle cases, 
the spherical radioactive source is considered to be located on the interface between 
the air and skin tissue, or sometimes between the air and the surface of the clothing.  
Therefore minor modifications of VARSKIN MOD2 were necessary to address an 
internal source in a body (sphere source submerged in water). 
The results are plotted together as a function of various microsphere in figure 
IV-7.  As shown in figure IV-8, the larger the diameter of the microsphere, the lower 
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the dose rate obtained, because of self-absorption in the source matrix.  The dose 
reduction ratio, however, was not as rapid as the volume increase ratio, but it was 
significant for relatively small size changes.  For example, a 0.03 cm radius 
microsphere is 1728 times larger than the 25 µm radius microsphere that was used for 
animal studies (this radius is in the acceptable range in quality control, 0.00265 cm ± 
7%), but the dose rate was reduced by less than half.   
Dose rates achieved through DPK and MCNP were compared.  As shown in 
figure IV-9, (a) through (f), dose rate was plotted against distance around spheres from 
50 µm to 0.3 cm in diameter.  From these calculations, DPK method generally showed 
higher dose rates than that of the MCNP for short distances from the spheres, but the 
MCNP showed higher values than that of the DPK at greater distances. 
 
IV-5-5. DPK and MCNP results fitted to a nonlinear function for microspheres as a 
function of diameter 
MCNP result was fitted to a nonlinear function using eq. (4-1) with the 
ORIGIN® spreadsheet program, and it was compared with the results from DPK 
analysis.  Calculated parameters were tabulated in table IV-1.  There are no 
correlations among the parameters among the spheres were irrelevant, as Prestwich et 
al. (1995) and Prestwich (1996) suggested, but DPK results agreed well for small 
distances.   
As shown in table IV-2, DPK results corresponded well with MCNP analysis 
(within 67%) for distances up to 0.64 cm.  For shorter distances, including the 
clinically critical area (~ 0.28 cm), discrepancies between DPK and MCNP were  
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Figure IV-9. Comparison of dose rate between DPK and MCNP calculation as a 
function of microsphere radius 
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Figure IV-9. Continued 
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Figure IV-9. Continued 
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Table IV-1. Calculation parameters used for non-linear fit. 
(Diameter is for microspheres) 
 
Diameter (cm) a1 λ a2 µ x0 α 
0.005 85.27034 10.04676 64203.45 50.65289 -1.74369 0.58652
0.06 160.693 36.44154 229.3349 10.82913 1.09E+18 2.74E+22
0.1 60.17832 25.85934 58.41765 9.23102 0.66914 0.05256
0.14 28.40219 18.3659 31.88018 8.27584 0.59277 0.06356
0.2 12.34774 17.04632 22.53743 8.36187 0.58443 0.07485
0.3 2.80239 18.25005 16.08921 9.27542 0.62432 0.0417
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Table IV-2. Ratio of DPK and MCNP calculations for microspheres  
as a function of diameter 
 
Ratio (DPK/MCNP), just below are diameter of microspheres in cm Distance 
(cm) 
0.005 0.06 0.1 0.14 0.2 0.3 
0.04 1.0079 1.0645 1.1236 1.1473 1.1492 1.1365 
0.08 1.0303 1.0636 1.0695 1.0701 1.0762 1.0390 
0.12 1.0528 1.0248 1.0085 1.0387 1.0276 0.9830 
0.16 0.9997 0.9930 0.9895 1.0207 0.9939 0.9452 
0.20 0.9878 0.9862 1.0111 1.0003 0.9658 0.9252 
0.24 1.0191 1.0077 1.0679 0.9861 0.9350 0.9087 
0.28 1.0826 1.0557 1.1458 0.9555 0.9058 0.8931 
0.32 1.1731 1.1170 1.2403 0.9263 0.8707 0.8711 
0.36 1.2776 1.178 1.3462 0.8843 0.8322 0.8412 
0.40 1.3924 1.2056 1.4370 0.8387 0.7922 0.7937 
0.44 1.5043 1.2975 1.5074 0.7787 0.7631 0.7402 
0.48 1.5983 1.3180 1.5411 0.7397 0.7126 0.6780 
0.52 1.6672 1.2949 1.5141 0.7044 0.6814 0.6148 
0.56 1.6602 1.2149 1.4204 0.6871 0.6689 0.5685 
0.60 1.5949 1.0807 1.2571 0.6947 0.6464 0.5699 
0.64 1.4430 0.8926 1.0384 0.7223 0.6360 0.6600 
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generally around 10%.  These results indicate that using analytical fit of MCNP results 
for a quick estimation will not significantly skew the results for pre-clinical 
application. Discrepancies between the fitted and MCNP calculated data were 
especially small for larger sphere diameters. 
According to the calculation results, DPK overestimated the dose rate near the 
source, but over longer distances MCNP overestimated the dose more than DPK 
calculation, respectively.  This is perhaps due to bremsstrahlung X-rays from source 
media that were not properly incorporated into the DPK calculation. This effect has 
been documented elsewhere (Cho 1997).  Also, using different beta spectrum 
generation methods (in this case, SADDE MOD2 was used in DPK while LOGft used 
in MCNP), may affect the discrepancy between these two methods.  Table IV-2 lists 
data only up to 0.64 cm distant from the source surface, because beyond that range the 
total accumulated dose is comparable with the radiation dose from natural background, 
and also exceeds X90 distance (~ 0.49 cm).  Since the activity of a microsphere for 
therapeutic use in a hepatic tumor is in the order of only tens of Bq (around 50 Bq for 
Campbell et al. 2001), data from beyond this distance is not significant.  For AVM 
treatment, lower activity levels are needed to induce hyperplasia of arterial walls (thus 
clogging unwanted arteries), so data from distances over 0.6 cm can be disregarded for 
this therapeutic application as well. 
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IV-6. Conclusions 
Dosimetric characteristics of 142Pr were estimated using MCNP and DPK 
calculations for dose rates around the source as a function of central axial distance. 
For the point source, the dose rate as a function of distance in the water was 
calculated using different dose calculation methods with the different spectrum 
generation codes LOGft and SADDE MOD2.  The LOGft-generated beta input 
showed higher dose rates than the SADDE-generated input for all the distances except 
those very close to the detector point (~ 0.04 cm).  However, results from calculations 
using SADDE MOD2, DPK and MCNP agreed to within 20%. 
The dose profile of 142Pr stent was similar to that of 32P (calculated through 
analytical fit by Prestwich in a previous study), particularly with regard to the end-
point beta energies, although the dose fall off of 142Pr was just a little greater than that 
of 32P (the end-point beta energy (Emax = 2.16 MeV) is high enough for therapeutic 
uses).  These results indicate that 142Pr could serve as an alternative beta brachytherapy 
source that could meet short half-life and cell proliferation rate requirements.  It also 
has potential uses as an ophthalmic applicator, as its dose profile is comparable to that 
of 90Sr/90Y, the ophthalmic applicators currently in use. 
142Pr can easily be obtained by irradiation in a low-fluence reactor in a 
relatively short time, because of its high thermal neutron cross section (11.4 barn) that 
is significantly higher than a typical beta source such as 32P (0.18 barn).  In addition, 
142Pr is not a bone-seeker such as 90Sr/90Y. 
Furthermore, praseodymium can be mixed as a glass type with other inorganic 
materials to achieve a high ratio (up to around 80w/o) that eases the difficulties of 
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source fabrication.  This high enrichment capability facilitates clinical applications 
such as radioactive microspheres for the treatment of hepatic tumors and AVM 
treatment. 
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CHAPTER V 
 
DOSE BACKSCATTER FACTOR CALCULATION FOR  
SELECTED BETA SOURCES 
 
V-1. Introduction  
Brachytherapy methods are being used more frequently to treat arterial 
diseases and in recent applications of radioisotopes to treat tumors.  Specifically, use 
of beta emitters in the treatment of arterial disease is now preferred over gamma 
emitters both because it reduces the dose to the medical staff and because the short 
range of beta particles results in the less radiation exposure to peripheral healthy tissue 
around the thin arterial wall.  The radioisotopes 32P and 90Sr/90Y have been extensively 
studied for these applications.  However, other isotopes may hold promise for future 
applications in intravascular brachytherapy. Of these, the beta emitters 45Ca, 142Pr, and 
185W were selected for backscatter calculations in this study because the high beta 
yield makes the gamma contribution to dose negligible. 
However, few of these isotopes can be injected directly into the tumor site.  For 
example, 32P and 90Sr/90Y are generally used in solution in a thin-walled container for 
angioplasty and 142Pr must be mixed or encased with other materials because the 
element decomposes on contact with blood.  Likewise, support materials are needed 
for a liquid source used in angioplasty and this can affect the dosimetry.  If the support 
materials or the encased source materials have high atomic number (Z) compared with 
tissue, there could be significant electron backscattering effects in the vicinity of the 
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tissue/source boundary. While not always detrimental (some researchers have 
attempted to use this effect in external electron therapy to increase the dose to tumor 
cells (Das et al. 1995)), for precise dose planning this backscattering effect must be 
taken into account. To study the effects of electron backscatter in beta brachytherapy, a 
variety of possible support or source matrix materials with Z numbers from 8 to 78 
were chosen for each radioisotope.  
Besides the effect of source fabrication materials, calcified plaque in the 
arterial wall can perturb dose, and contrast agents (used for imaging purposes during 
the source injection) were also considered as backscatter materials. Because contrast 
agents contain a considerable percentage of iodine (Z=53, see table V-1.), these 
materials are expected to contribute to the backscatter effect.  Contrast agents are 
typically present for only a small part of a procedure; occasionally however, they are 
used to inflate angioplasty balloons, and are therefore present during the entire 
procedure.  In these cases they can be a significant factor in dose perturbation (Li 
2001). 
There have been many studies on beta-particle backscatter, and Z-dependent 
formulae predicting backscatter effects differ from author to author (Sharma et al. 
1980, Baily 1980, Chibani 2001, Pandey et al. 1989, Nunes et al. 1993a, Bafandeh 
1992).  Cho (1997) observed that the data indicating that electron backscattering is 
dependent on the energy of the primary electron is inconsistent due to different 
experimental settings and the limited spatial resolution of the detectors.  Although the 
backscatter factor can vary for different source geometries, the values obtained for a 
point source, analytically fit, can be generally applied to the DPK method used in  
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Table V-1. Composition of calcified plaque and contrast agents (Nath et al. 2001) 
Calcified plaque Hypaque Omnipaque Elements 
(Atomic No.) Composition (%) 
H (1) 3.10 7.42 6.90 
C (6) 31.26 7.88 14.96 
N (7) 0.99 1.67 2.76 
O (8) 37.57 58.92 50.49 
Na (11) - 1.38 - 
Cl (17) 0.05 - - 
Ca (20) 27.03 - - 
I (53) - 22.73 24.89 
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Chapter IV for the more complex geometries through iteration of integration for 
volume sources.  The beta backscatter factor, one of the most prominent secondary 
effects, should be properly incorporated into DPK precise dose planning where the 
interface exists between large Z number media. 
Electron backscattering of 32P and 90Sr/90Y beta emitters has been extensively 
studied through both calculation and experiment, but except these radioisotopes, the 
backscattering study usually addressed only mono-energetic beams and various 
difficulties that can occur in the lower energies of the beta spectrum during 
experiments.  The values obtained for mono-energetic beams are difficult to apply to 
beta emitters because of differences in the spectrum of energies emitted.   
To use mono-energetic data, one must obtain the beta energy spectra of the 
source; in this study SADDE MOD2 (Reece et al. 1989) code was used to obtain this 
data. Through the SADDE MOD2, the beta spectra was computed and divided into 
150 discrete energy bins, and these bins were normalized to unity and incorporated 
into the MCNP input.  Using MCNP, the dose backscatter factor was calculated for a 
point source on the interface between two different media.  This enhanced dose was 
compared to the dose in a homogeneous media (e.g., water) and the backscatter factor 
calculated. 
 
V-2. Materials and methods  
Backscatter factors for the beta emitters were calculated using MCNP 4C 
Monte Carlo code (Briesmeister 2000).  The MCNP is a general-purpose particle 
transport code that can simulates three major particles, i.e. neutrons, gammas and 
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electrons. For electron transport, bremsstrahlung production and knock-on electrons 
can be incorporated to the final result.  In order to make the results fit within the 
desired error range (< 10 %), one million histories were used per MCNP run.  
However, due to lower average energy of 45Ca and 185W (see table V-2), 3 or 5 million 
histories were necessary depending on the error range.  The beta emitter was assumed 
to be a dimensionless point source emitting its characteristic beta energy spectrum.  
The spectrum was generated using 150 discrete energy bins through SADDE MOD2.  
Input to the SADDE code included: the decay mode, the atomic number of the 
transition product nucleus, the atomic mass of the decaying isotope, the endpoint 
energy of the specific decay path, and the degree to which the transition is forbidden. 
The spectra of 90Sr and 90Y were combined because they are in secular equilibrium and 
the combination of these two isotopes is sometimes preferred for practical reasons, 
including the high activity of 90Y and the long half-life of 90Sr (Fox 2002).  All the 
following calculations utilize their combined spectra. 
The geometry used in this backscatter factor calculation was taken from Cho 
and Reece (1999), which was initially adapted from Nunes et al. (1993a, 1993b).  The 
difference between Cho and Reece’s work and this study is that they used the EGS4 
Monte Carlo code, and their calculations were for monoenergetic point sources and a 
32P point source.  Although they calculated factors for five electron energies (0.1, 0.5, 
1.0, 2.0 and 3.0 MeV) to cover typical beta spectra, and they proposed interpolation fit 
to predict backscatter factors for different materials, questions still remain about direct 
application of these data to beta brachytherapy seeds, which have a broad range of 
spectra and a unique shape. Therefore, using individual spectral data provides more  
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Table V-2. Radioisotopes used in this study.a 
Radioisotope Emission 
Maximum 
energy (keV) 
Average energy 
(keV) Half-life 
32P Beta 1710 695 14.28 days
90Sr beta,  
low yield gamma 
546 196    28.5 years 
90Y beta,  
low yield gamma 
2282 934  2.671 days
45Ca Beta 256 77 163.8 days
142Pr beta,  
low yield gamma  
2160 810 19.12 hours
185W Beta 433 127 75.1 days
 
a. All data from http://t2.lanl.gov and rounded to significant digits. 
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accurate results when calculating backscatter factors for a brachytherapy seed.  The 
simulated geometries as well as geometries used in the definition of backscatter factor 
are shown in figure V-1. (a). The dose backscatter factor is given by 
1001
)(
)(
)( ×


−


=
rD
rDrB
w
s       (5-1) 
where B is dose backscatter factor in percentage and r is the distance from the 
interface. Ds and Dw represent backscatter dose enhancement or decrement (usually 
enhancement) by the scatterer, with and without scattering effects, respectively.  From 
this definition, the dose backscatter factor is calculated using the ratio of doses 
between the two media.  
When simulating radiation transport using MCNP, the dose collecting detectors 
were constructed as a series of cylinders with the dimensions shown in figure V-1. (b). 
The backscatter materials were assigned to the lower volume as a scatterer and the 
detectors were located in the water media at various distances from the interface.  The 
backscatter materials were chosen depending on each source’s characteristics, and 
their Z numbers varied from 8 to 78.  Contrast agents used as scatterers in this study 
were Hypaque and Omnipaque. The density of Hypaque is 1.32 g/cm3, and 
Omnipaque’s density is 1.406 g/cm3.  Calcified plaque on the arterial wall can also be 
considered a scatterer; the density of this material was assumed to be 1.84 g/cm3.  All 
these data were obtained from Nath et al. (1999a), and composition of these materials 
is listed in table V-1.  Nath et al. (2001) calculated the photon perturbation effect as 
well as the shielding effect for selected photons (125I, 192Ir and 103Pd) and beta emitters 
(90Y, 32P and 188Re). 
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water 
water 
water 
scatterer 
    Dose by water = Dw                Dose by scatterer = Ds 
(a) Schematic for the definition of the dose backscatter factor 
 
 
 
 
 
 
 
 
 
 
 
detectors  
(cylinder: r = 0.5 cm, h = 0.002 cm) 
R = 1 cm 
water 
z-axis 
(0,0,0) 
cylinder 
t = 2 cm 
scatterer 
x-axis 
point source 
 
(b) MCNP input geometry for dose backscatter factor (half the geometry along z-
axis shown here, not to scale) 
 
Figure V-1. Schematic drawings of backscatter factor calculation setup 
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For the 142Pr source, the elements aluminum, silicon, oxygen, praseodymium 
were used. The composition ratio of the Pr source material was 10.5a/o praseodymium, 
63.2a/o oxygen, 10.5a/o aluminum, and 15.8a/o silicon.  The density of this material was 
assumed to be 3 g/cm3. These source-matrix materials are currently under 
investigation for use in the application of 142Pr.  The backscattering effect for the 142Pr 
source material (Pr, O, Al and Si; scatterer) interacting with calcified plaque (absorber) 
was calculated.  The same calculations were made for the source material (scatterer) 
used with Hypaque (absorber), and the source material (scatterer) was also used with 
Omnipaque (absorber). 
The beta spectra used in the calculations were obtained using SADDE MOD2 
as described above, and the end point energies of the sources used are listed in table V-
2.  However, some discrepancy exists between the average energy listed in the table V-
2 and the actual average used in the calculation.  This discrepancy arises because of 
the use of energy bins for MCNP input.  However, the discrepancies between listed 
and used values do not exceed 30 keV in any case. 
 
V-3. Results 
V-3-1. Trend of backscattering effect 
As expected, the backscatter effect was more significant in the immediate 
vicinity of the interface between the two media (see figures V-2~V-12).  All the plotted 
data shown in the figures has an error less than 10%, as calculated by the embedded 
statistical check in MCNP code.  For most of the beta emitters, maximum backscatter 
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factors were observed at 0.1 cm or less from the interface.  Bafandeh (1992) stated that 
the saturation of the backscatter effect occurs at about 1/5 of the maximum range of 
the particles in the material.  Generally, the higher the Z number of scatterer, the 
higher the backscatter factor observed.  
The dose backscatter factor for 32P in the platinum medium (Z=78) reached 
more than 48% around 0.09 cm and dropped thereafter as shown in figure V-2.  At the 
other extreme, the maximum backscattering factor was less than 3.4% at 0.051 cm for 
32P in the oxygen medium (Z=8).  The result for the aluminum scatterer closely 
matched with Cho and Reece (1999) calculated with EGS4; the comparison of these 
results will be discussed in a later section (V-3-3).  With regard to contrast agents, 
significant backscatter factors (more than 30%) were observed for both Hypaque and 
Omnipaque (see figure V-3).  This suggests that contrast agents will affect dose 
because of the iodine content.  Calcified plaque generated a 10% to 12% backscatter 
factor at distance between 0.007 cm and 0.1 cm.  In order to confirm these results into 
a more realistic clinical situation, contrast agents and calcified plaque 0.1 cm thick 
were used as scatterers in identical geometry assemblies.  In this situation the 
scattering surface was sandwiched between 4 cm high water cylinders.  This geometry 
is essentially the same as the geometry depicted in figure V-1, except for the thickness 
of the scattering agent.  The results of these trials will be compared with the results 
generated by normal geometry (as in figure V-1) in section V-3-4.  However, these 
results assume that the contrast agents filled 100% of composition of the blood vessel; 
in clinical situation, the layer of contrast agent would be thinner. 
 
 86
0.1
1
10
100
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45
Distance (cm)
%
 D
os
e 
ba
ck
sc
at
te
r f
ac
to
r O
Al
Si
P
Ti
Ni
Pt
 Figure V-2. Dose backscatter profile of 32P for different scatterer (analytical fits shown 
as lines hereafter) 
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 Figure V-3. Dose backscatter profile of 32P for calcified plaque and contrast agents 
As shown in figures V-4 and V-5, backscatter profile of 90Sr/90Y was very 
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similar to that of 32P, due to their similar average energies. 
It was more difficult to characterize the backscatter profile of 45Ca (average 
energy 77 keV) compared with other, higher, beta energy sources. As shown in figure 
V-6, backscatter profiles for high Z materials are much more like other high-energy 
beta emitters than the profiles from low-Z materials such as oxygen.  Although more 
particle histories (3 million or 5 million) were used for these calculations, only data up 
to 0.045 cm was obtainable because of the weak penetrating power of 45Ca beta 
particles (see figures V-6 and V-7).  Inspection of figure V-6 shows larger fluctuations 
in the backscatter for low Z scatterers beginning around 0.025 cm. Similar fluctuations 
are visible in calcified plaque, which is also composed of low Z material.  This 
phenomenon has been observed and documented by Nunes et al. (1993b).  In their 
studies they observed unusually large backscatter between 300 to 400 mg/cm2 in 
Mylar scatterer for a 32P source, but could not achieve any clear proof of this 
phenomenon.   
In order to observe whether differences in the detector thickness influenced this 
result because of the short CSDA (continuous slowing down approximation) range of 
low energy beta emitters, 1 µm thick detectors and 10 million histories were used 
instead of 0.002 cm thick detectors and 3 million histories.  In another change, ITS 3.0 
algorithm was used instead of the inherent MCNP algorithm.  As stated in section II-4-
7, the MCNP inherent energy uses cross section data from where the group of the 
electrons started, and ITS’s algorithm uses data from the closest energy group.  This 
makes the MCNP inherent algorithm result somewhat higher than that of ITS. Despite  
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Figure V-4. Dose backscatter profile of 90Sr/90Y for different scatterers 
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 Figure V-5. Dose backscatter profile of 90Sr/90Y for calcified plaque and contrast 
agents 
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Figure V-6. Dose backscatter profile of 45Ca for different scatterers 
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Figure V-7. Dose backscatter profile of 45Ca for calcified plaque and contrast agents 
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the using much smaller detector and different algorithm, fluctuation of dose 
backscatter factor increased in the tail area of the plot, as shown in figure V-8.  These 
results indicate that the abrupt increase and decrease is not dependent on detector 
thickness. It also suggests that one should be cautious in the calculation and 
experimental determination of backscatter factors for low energy beta emitter in low Z 
scatterers.  Perhaps this effect may due to the statistical fluctuation of MCNP which is 
prominent at lower beta energy. Since no conclusions can be drawn at present, further 
study is recommended. However, this fluctuation may not be an important 
phenomenon in clinical situations because the fluctuation range is near the end of, and 
even beyond, the X90 distance of 45Ca (0.0216 cm in water).   
Therefore, dose backscatter beyond this range is composed of secondary 
particles whose energies are much lower than the primary beta energy.  The highest 
backscattering occurred around 0.003 to 0.005 cm much nearer to the source than any 
other isotopes because of the short beta range of 45Ca.  
For 142Pr, only the four elements previously mentioned above and their 
compound material were used as a scatterer.  The result of water to scattering materials 
composing 142Pr seed is shown in figure V-9.  The compound materials of microsphere 
for AVM treatment used in the animal tests were O, Al, Si and Pr. In the figure, 
contribution by each of the material and the effect of mixed material of these elements 
is also shown.  As expected, the higher the atomic numbers in the scatterer, the higher 
the dose backscatter factor obtained.  Although the compound material was composed 
of only 10.5a/o of praseodymium, it showed higher dose backscatter profile than the 
praseodymium alone.  Several other high Z materials were chosen and tested under  
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represents composition material of Al, O, Si and Pr) 
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same conditions, and it was verified that the high Z element dominates the backscatter 
effect even when it comprises a smaller portion of the compound than the low Z 
element. Backscatter factors for Hypaque and Omnipaque showed almost the same 
tendency, as illustrated in figure V-10. 
  The dose backscatter factor was calculated for arterial wall materials, such as 
calcified plaque, Hypaque and Omnipaque, against 142Pr source compound material.  
In this case, the detector was located in the arterial wall material.  As shown in figure 
V-11, dose backscatter factors were negative except for the calcified plaque, which 
showed a dose backscattering factor of 12-15%, most likely due to large differences 
between the Z numbers.  These results are not surprising if we take into account the 
effective atomic numbers of these materials.  It can be concluded, therefore, that if the 
source material has an effective atomic number similar to that of the contrast agent, the 
backscattering effect can be neglected.  
As shown in figures V-12 and V-13, dose backscatter factor have been well 
characterized graphically, like backscattering profile of other beta emitters.  Even 
though 185W has low average energy (127 keV), it did not show any of the large 
fluctuations at greater distances typical of low Z material such as 45Ca.  
 
V-3-2. Analytical fit 
The result presented in previous section can be adapted through analytical fit 
for each backscattering material and the equations given by (Cho and Reece 1999, 
Cross et al. 1992),  
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 Figure V-10. Dose backscatter profile of 142Pr for calcified plaque and contrast agents 
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 Figure V-12. Dose backscatter profile of 185W for different scatterers 
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 Figure V-13. Dose backscatter profile of 185W for calcified plaque and contrast agents 
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where B is the percentage dose backscatter factor and r is the distance from the 
interface in cm.  The results are presented in tables V-3 to V-7. 
As shown in table V-3, the fit for 32P was excellent, with a generally high 
correlation coefficient R2 (> 0.96), except for the oxygen medium (R2 = 0.93) for 
distances up to 0.5 cm, for which it was slightly lower.  However, a correlation 
coefficient of more than 0.95 was obtained when it was fitted to a distance of 0.019 cm 
for the oxygen scatterer. 
The calculations for 90Sr/90Y, as listed in table V-4, showed excellent fit (R2 > 
0.95) except for the oxygen medium (R2 ~ 0.93).  Also note that the data for the 
aluminum medium is only valid up to 0.7 cm, while others are valid though 0.9 cm. 
In the case of 45Ca (table V-5), calcium, tungsten and platinum showed high 
correlation coefficients.  For low Z materials, such as aluminum and silicon, the 
correlation coefficients hardly exceeded 0.9 for any of the distances investigated in 
this study.  For calcified plaque and contrast agents, acceptable correlation coefficients 
(> 0.90) were obtained for distances through 0.025 cm for normal geometry (contrast 
agents and calcified plaque 2 cm in depth).  When the scatterers were only 1 mm thick, 
the correlation was improved (> 0.94).  The use of more realistic geometries in this 
study generated more reliable data; however, dose backscatter factors for low energy 
(less than 100 keV) electrons using low Z scatterers should be investigated further to 
improve the correlation factor.  
As shown in table V-6, all the correlation coefficients exceeded 0.96 for  
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Table V-3. Dose backscatter factor for 32P with seed composing materials, calcified 
plaque and contrast agentsa 
 
Elements 
(Atomic No.) 
m0 m1 m2 m3 R2 
O (8) - 2.1159 - 7.9958 - 3.9196 -0.5643 0.93 
Si (14) - 7.8617 - 32.675 - 16.397 -2.4676 0.9918 
P (15) - 7.5161 - 33.844 - 17.138 -2.5978 0.9933 
Ti (22) - 11.305 - 53.216 - 27.784 -4.2976 0.9935 
Ni (28) - 11.403 - 63.89 - 34.618 -5.4903 0.9892 
Pt (78) - 4.2276 - 100.03 - 59.621 -10.055 0.962 
Calcified plaque - 7.302 - 30.615 - 15.35 -2.2886 0.9931 
Hypaque - 14.215 - 81.081 - 44.778 -7.1826 0.9884 
Omnipaque - 13.743 - 82.396 - 45.831 -7.3786 0.989 
Calcified plaque* - 9.543 - 32.734 - 15.97 -2.3018 0.9774 
Hypaque* - 10.279 - 69.22 - 36.964 -5.6589 0.9905 
Omnipaque* - 10.927 - 72.29 - 38.922 -6.0126 0.9916 
 
a. Valid distance: 0 - 0.5 cm 
*Thickness of Hypaque, Omnipaque and calcified plaque is 1 mm, valid distance is up 
to 0.6 cm for Hypaque and Omnipaque, 0.4 cm for calcified plaque 
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Table V-4. Dose backscatter factor for 90Sr/90Y with seed composing materials, 
calcified plaque and contrast agentsa 
 
Elements 
(Atomic No.) 
m0 m1 m2 m3 R2 
O (8) - 0.2437 - 5.27 - 2.4011 -0.3132 0.9275
Al (13)b - 3.8143 - 28.106 - 15.219 -2.4805 0.9766
Ti (22) - 3.2766 - 43.964 - 24.256 -3.9594 0.9867
Ni (28) - 2.7812 - 52.952 - 30.114 -5.0122 0.9808
Pt (78) + 4.6575 - 90.115 - 55.9 -9.8036 0.9555
Calcified plaque - 2.2409 - 24.677 - 12.662 -1.8352 0.9824
Hypaque - 3.0572 - 62.237 - 34.531 -5.4465 0.9894
Omnipaque - 2.4976 - 63.612 - 35.737 -5.6722 0.9917
Calcified plaque* - 3.2042 - 24.892 - 12.736 -1.8593 0.9842
Hypaque* - 2.8861 - 55.24 - 29.62 -4.5127 0.9871
Omnipaque* - 2.7714 - 57.575 - 31.289 -4.805 0.9861
 
a.Valid distance: 0 - 0.9 cm,  b.Valid distance: 0 –0.7 cm 
*Thickness of Hypaque, Omnipaque and calcified plaque is 1 mm,  
Valid distance is up to 0.7 cm 
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Table V-5. Dose backscatter factor for 45Ca with seed composing materials, 
calcified plaque and contrast agentsa 
 
Elements 
(Atomic No.) 
m0 m1 m2 m3 R2 
O (8) - 31.648 - 40.003 - 15.725 -2.0811 0.9228 
Al (13) - 2.5642 + 8.5211 + 12.028 +2.5357 0.7973 
Si (14)b - 70.615 - 86.3 - 30.233 -3.5971 0.8723 
Ca (20) - 102.03 - 129.41 - 46.452 -5.576 0.9975 
Ni (28) - 124.84 - 158.88 - 55.388 -6.3947 0.9379 
W (74) - 284.93 - 407.47 - 164.46 -21.769 0.9604 
Pt (78) - 262.79 - 375.81 - 149.13 -19.386 0.9523 
Calcified plaquec - 159.61 - 215.18 - 89.675 -11.951 0.944 
Hypaquec - 169.75 - 260.17 - 114.17 -15.942 0.9058 
Omnipaquec - 134.87 - 221.84 - 100.97 -14.45 0.9321 
Calcified plaque* - 95.098 - 129.07 - 52.022 -6.5446 0.982 
Hypaque* - 278.64 - 408.66 - 180.3 -25.441 0.958 
Omnipaque* - 298.73 - 442.09 - 197.63 -28.192 0.9433 
 
a.Valid distance: 0 - 0.045 cm, b.Valid distance: 0 - 0.035 cm 
c.Valid distance: 0 - 0.025 cm 
*Thickness of Hypaque, Omnipaque and calcified plaque is 1 mm, valid distance is up 
to 0.041 cm for calcified plaque and Omnipaque, 0.039 cm for Hypaque 
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distances up to 0.7 cm, and can readily be applied to analytical calculation of 142Pr.  
For 185W, correlation coefficients were well above 0.96 except for the oxygen 
scatterer (see table V-7) even though its average energy was only 127 keV. 
 
V-3-3. Comparison with other results 
In order to check the validity of the spectrum generated by SADDE MOD2, the 
results were compared with previous studies (Nunes et al. 1993a, 1993b, Cho and 
Reece 1999) and which dealt with 32P point source.  Although Nunes et al.’s (1995) fit 
was obtained from aluminum/Mylar interface, the results agreed for areas in the 
vicinity of the interface (figure V-14).  Cho and Reece’s (1999) results much more 
closely matched those of the MCNP using the ITS 3.0 algorithm rather than the 
MCNP inherent algorithm (figure V-15).  However, large discrepancies were observed 
at the 500 cm/mg2 depth.  This disagreement may have been caused by different 
physics models between MCNP and EGS4, or by different spectrum generating codes.  
Furthermore, when using Monte Carlo code (i.e. MCNP), choosing a different energy 
grouping method alone may make a significant difference (up to 14%, figure V-15).  
Usually, the MCNP inherent algorithm shows higher values than those of the ITS 
algorithm.  The results from the MCNP calculation were generally higher than those 
from the EGS4 for any distances, as it was previously demonstrated by other studies 
(Wang et al. 1999).  
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Table V-6. Dose backscatter factor for 142Pr with seed composing materials, calcified 
plaque and contrast agents.a Compound is composed of O, Al, Si and Pr 
 
Elements 
(Atomic No.) 
m0 m1 m2 m3 R2 
O (8) -1.4600 -8.5427 -4.5698 -0.7013 0.9752
Al (13) -4.1208 -28.8120 -15.5880 -2.4912 0.9882
Si (14) -4.8365 -32.0370 -17.3180 -2.7664 0.9914
Pr (59) -1.7400 -86.7840 -53.3330 -9.2250 0.9683
Compound -6.029 -59.23 -32.954 -5.3099 0.9909
Calcified plaqueb -0.496 -22.466 -11.671 -1.7031 0.9764
Hypaqueb 15.866 -32.501 -20.008 -3.1457 0.9960
Omnipaqueb 10.069 -43.089 -25.423 -4.0062 0.9970
Calcified plaque* - 3.261 - 25.021 - 12.592 -1.8171 0.9906 
Hypaque* - 3.7837 - 59.804 - 33.621 -5.3487 0.9937  
Omnipaque* - 3.3196 - 61.294 - 34.556 -5.4859 0.9924
 
a.Valid distance: 0 - 0.7 cm b.Valid distance: 0 - 0.051 cm 
*Thickness of Hypaque, Omnipaque and calcified plaque is 1 mm, 
Valid distance is up to 0.8 cm 
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Table V-7. Dose backscatter factor for 185W with seed composing materials, 
calcified plaque and contrast agentsa 
 
Elements 
(Atomic No.) 
m0 m1 m2 m3 R2 
O (8) b - 14.98 - 20.998 - 8.2689 -1.0787 0.9036 
Al (13) - 33.344 - 48.39 - 17.349 -2.06 0.9878 
Si (14) - 46.432 - 68.982 - 26.84  -3.4722 0.9933 
Ti (22) - 65.941 - 103.05 - 40.174 -5.13 0.9945 
Ni (28) - 73.388 - 118.66 - 46.507 -5.9293 0.9943 
W (74) - 124.92 - 234.08 - 102.66 -14.387 0.9823 
Pt (78) - 136.24 - 254.32 - 113.01 -16.052 0.9696 
Calcified plaquec - 46.944 - 70.356 - 27.4 -3.2045 0.9652 
Hypaquec - 127.69 - 219.21 - 98.288 -13.781 0.985 
Omnipaquec - 144.21 - 247.98 - 113.23 -16.135 0.9732 
Calcified plaque* - 62.143 - 93.448 - 38.683 - 4.9385 0.9948 
Hypaque* - 167.3 - 275.97 - 124.95 -17.77 0.9897 
Omnipaque* - 175.05 - 291.11 - 133.24 -19.098 0.9878 
 
a.Valid distance: 0 - 0.08 cm, b.Valid distance: 0 - 0.045 cm 
*Thickness of Hypaque, Omnipaque and calcified plaque is 1 mm, 
Valid distance is up to 0.051 cm 
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V-3-4. Thinner contrast agents and calcified plaque: a more realistic approach 
In real physiological situations, contrast agents and calcified plaque cannot 
achieve the 2 cm thickness.  In order to create realistic Monte Carlo simulation 
geometry based on the assumption that the contrast agents spread through  
the arterial wall, layers of contrast agents and calcified plaque with only 1 mm thick 
were used as scattering material.  Significant differences were observed near the 
interface area when it was compared with 2 cm thickness.  As shown in figure V-16 
(a) through (e), in most of the cases, except 90Sr/90Y (see figure V-16 (b)), 
discrepancies were prominent near the interface, but decreased during the mid-range 
distances and increased again in the tail of the graph.  The discrepancy was less than 
10% in the mid-distance range.  The values for these comparisons were all taken from 
analytical fit values.  From these results, it is evident that the thickness of the materials 
composing the arterial wall was less effect on dose than expected, even when 
considering large differences in thickness.  However, uncertainties regarding the dose 
backscattering effect of very small distances still exist, and should be taken into 
account in clinical work or further experimentation. 
 
V-3-5. Log(Z+1) dependence 
As Baily (1980) proposed, beta emissions were dependent on log (Z+1) even 
though this study was performed for energy spectra rather than mono-energetic 
sources.  As shown in figure V-17, all the beta emitters corresponded well with high 
correlation factors (R2 > 0.99) except for the 45Ca spectrum (0.959) at a distance 0.011 
cm from the interface.  Although other formula have been suggested for broad energy  
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Figure V-16. Backscatter factor ratio of 3 cm to 1 mm thick (3 cm/0.1 cm) contrast 
agents and calcified plaque  
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Figure V-16. Continued 
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Figure V-17. Log (Z+1) dependence of dose backscatter factor at 0.011 cm distance 
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application, such as {Electron Backscatter Factor = A - B.exp(-kZ)} (Klevenhagen 
1991), log (Z+1) dependence was excellent expression for this study, which dealt with 
relatively low energy (less than 2.5 MeV end point energy) brachytherapy applications. 
For compound materials composed of calcified plaque, contrast agents and 142Pr seeds, 
the effective atomic number (Zeff) was needed.  In order to obtain this, the following 
equation following was used. 
m m
nn
mm
eff ZaZaZaZ +++= ...2211 , (5-3) 
where a1 to an are the fractional numbers of electrons per gram contained in a 
compound of atomic number Z1 to Zn. The values of m that give the best fit range from 
3.4 to 3.8, but the best fit was obtained by 3.5 (Johns et al. 1983).  The value m varies 
with Z, with 3 for high Z and 3.8 for low Z material.  However, the value of 3.5 for m 
used in this calculation was an excellent log(Z+1) dependence for the compound 
material.  In order to calculate Zeff, parameters from Attix (1986) were used.  Zeff 
obtained by eq. (5-3), and is tabulated in table V-8. 
 
 
 
Table V-8. Effective atomic numbers of compound materials used in this study 
 
 Calcified 
Plaque 
Hypaque Omnipaque 142Pr source matrix 
material 
Zeff 13.93 32.69 33.62 29.84 
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V-4. Conclusions and discussions 
The backscatter effects of selected radioisotopes were simulated through use of 
MCNP code.  The backscatters were simulated using various materials that could be 
candidates for source composing or supporting materials as scattering agents.  In 
addition to those materials, calcified plaque and contrast agents that could be present 
on the arterial wall during the procedure were used as scatterers.  For intravascular 
brachytherapy, calcified plaque not only absorbs a fraction of the radiation dose to the 
endothelial cell of blood vessel but scatters the radiation back as well.  This 
backscattering effect is diminished because source supporting material and calcified 
plaque also attenuate the dose to the target wall.  However, since the diameter of a 
coronary vessel is usually smaller than 0.5 cm, impact of contrast agents may only be 
important for the target tissue in the few mm or even µm range.  Also, contrast agents 
would spread widely into the arteries and could give different results because their 
compositions and densities are higher than tissue (estimated to be that of water in this 
study).  As Nath et al. (1999b, 2001) already mentioned, the arteries will not be fully 
filled with these materials, so the backscatter factor calculated in this study will be 
somewhat higher than in a real situation.  On the other hand, backscattering from 
contrast agents in beta source brachytherapy would affect the dose to the target cell 
significantly and is therefore important, even though the contrast agents are 
administered in a with saline solution and dispersed through the arterial wall. 
In order to verify the validity of this study, results from previous studies that 
used 32P emitters with aluminum scatterers (experimental) and water (EGS4 
calculation based) were compared with these results.  They correlated reasonably well; 
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specifically, the ITS 3.0 based MCNP showed a stronger correlation with the EGS4 
calculation than the MCNP inherent algorithm.  
This comprehensive data on backscatter factor can readily brought bear on 
future applications of the DPK method, or as an aid to future applications of new low-
energy beta emitter sources, such as 45Ca, 185W and relatively high-energy 142Pr, which 
up to this point have been relatively unexplored.  For 45Ca, analytical fits for low Z 
material shows less correlation in the form of third order polynomial fit, meaning that 
exact dose backscatter estimation could be difficult in clinical situations.  Also, source 
matrix materials must be chosen carefully for 45Ca because of its high solubility (in 
blood) and low energy, and significant self-absorption and perturbation in the source 
matrix material are to be expected.  However, as long as high enrichment is an 
available option for 185W, it can be used alone and the dose backscatter factor is very 
predictable, so this isotope may be a good candidate for future application to 
brachytherapy source.  
The use of Zeff for compound material was also validated the log(Z+1) 
correlation.  For lower end point energies (45Ca), however, the correlation was lower 
than other emitters, yet still acceptable (R2 > 0.95). 
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CHAPTER VI 
 
CONCLUSIONS, DISCUSSIONS AND FURTHER STUDY 
 
The main purpose of this dissertation is to explore the dose profiles of 142Pr in 
various seed types, dose variation as a formation of microspheres in artery, and dose 
backscatter factor calculation for some beta sources that can be considered for 
brachytherapy purposes as well as currently used sources.   
Due to the rapid dose decrease around the beta source, it is extremely hard to 
obtain accurate data from experiments.  Therefore, Monte Carlo calculation is widely 
used as an alternative method to analyze dose trends of radioactive seeds for 
therapeutic purposes.  In this research, dose rate as a function of distance around the 
source was calculated using the MCNP code (Briesmeister 2000).   
Beta dosimetry of microspheres in brain arteries was explored.  The treatment 
methods of AVM can be determined by several factors such as size, location and 
radio-sensitivity of the nidus.  Using these factors, AVM can be treated with surgery 
or radiosurgery.  Sometimes, to enhance clinical result, both treatment methods are 
used together. However, if the location of nidus is hard to reach, stereotactic 
radiosurgery is solely used.  Although during the stereotactic radiosurgery, some 
healthy tissues can be saved by exact dose planning with most up-to-date equipment 
and software, sacrifice of healthy tissues is inevitable.  To protect the healthy tissues 
from unwanted side-effect from high-dose radiation, injection of microspheres into 
AVM feeding arteries was devised by Reece and Mawad (2001).  142Pr was especially 
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chosen as the material for this treatment because of high beta energy with a large 
thermal neutron cross section as well as low chemical toxicity.   
Until now, beta dosimetry of microspheres was only performed in 
macroscopically (Campbell et al. 2000, 2001, Zavgorodni 1996). In their study, they 
assumed the microsphere source as a point source and ignores all the secondary effects 
such as inter-shielding between microspheres and bremsstrahlung effects by using 
DPK method.   
In this study, beta dose calculation for 142Pr microsphere was performed 
various source geometries filled with microspheres. The calculation was performed for 
cylinders packed with microspheres using random packing methods.  Dose rate around 
the arterial wall was varied as a function of both size of arteries and microspheres. 
Combination of these two factors significantly affected the result.  These results will 
aid in dose planning by selection of size of microspheres for a specific arterial size.  
However, questions still remain for the random close packing ratio (roughly around 
50%) used in this calculation.  Although it is believed that the packing ratio in arteries 
may not show this percentage because of blood flow and arterial movement, this 
assumption may not affect dose values much where packing is optimized for effective 
arterial shunt.   
Therefore, more specific dose calculations are left for further study for various 
packing formations. This will include more comprehensive physiological data, or even 
voxelized phantom can be used if it guarantees that the resolution of the image is good 
enough to distinguish the packing of microspheres. 
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Dose characteristics of 142Pr radioisotope for radiotherapeutic application were 
analyzed with both Monte Carlo and dose point kernel (DPK) methods.  Since 142Pr 
has never been used for brachytherapy purposes, calculation of dose rate as a function 
of distance within a centimeter range with various source geometries is needed for 
clinical application.  The source geometries studied in this work are point, wire (solid 
cylinder), stent (cylindrical shell), disk, and sphere.  For a point source, spectrum data 
obtained from LOGft showed higher dose rates than data from SADDE MOD2.  142Pr 
stents had lower dose rates than 32P calculated by Prestwich (1996) for short distances 
around the source surface.  This result contradicts that 142Pr has higher maximum beta 
energy than that of 32P.  This may due to different dose calculation algorithms between 
DPK and MCNP.  As an ophthalmic applicator, 142Pr is very similar to that of 90Sr/90Y 
source currently being used.  Spherical geometry was carefully studied as a function of 
the diameter of the source because this isotope may be useful for future treatment of 
hepatic tumors and arteriovenous malformation (AVM) by injecting 142Pr 
microspheres through a catheter.  For simple geometries, such as point and sphere dose 
profiles, were calculated and compared with DPK calculations.  Specifically, results 
obtained by MCNP calculations for microspheres that can be used for AVM treatment 
was fit to nonlinear analytic function for a distance around the source and compared 
with the result from DPK calculations.  The results agreed well at interested distances 
from the source of clinical interest.  Variation of fitted and calculated values agreed 
better for larger diameter microspheres than for smaller ones.  From the dose fall-off 
trend, it is concluded that 142Pr could be a good source of beta rays that could replace 
current sources for certain cases such as radio-embolic treatment of AVM or radio-
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therapeutic treatment of hepatic tumor.  Results between Monte Carlo and DPK for 
multiple microspheres also remain for further study.   
Up to now, backscatter factors for beta particles have varied depending on the 
experimental setup and detector resolution for calculation, and were generally 
performed for monoenergetic electron beams, which make direct application of these 
factors to beta sources difficult.  The calculated values in this research can be readily 
incorporated into dose point kernel (DPK) methods using analytical fit methods.  This 
model can also aid in choosing a source support or mixing materials for beta 
brachytherapy sources.  Backscatter factor calculations were carried out with MCNP- 
4C for beta sources currently in use (32P and 90Sr/90Y), as well as other sources (45Ca, 
142Pr and 185W) with potentially useful as brachytherapy seed.  Specifically, the 
calculations used beta spectra generated by the SADDE MOD2 code.  The factors 
were calculated for point sources on the interface between the water and the 
surroundings, or between the material supporting the source and contrast agents 
commonly used imaging purposes in brachytherapy.  Due to high-Z material content 
(iodine, Z=53) in the contrast agent, significant dose backscatter was observed near the 
water interface.  Different cross-section algorithms in the MCNP code (inherent and 
ITS 3.0) affect the factor calculations. The results generated by the ITS 3.0 algorithm 
closely matched the EGS4 calculations for 32P.  The dependence of backscatter factors 
on log (Z+1) dependence (Baily 1980) was observed for all the beta sources with a 
high correlation coefficient, R (> 0.95). 
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